Loss of post-mitotic neurons from the adult brain underlies the pathology of neurodegenerative diseases and neurotoxin exposure. Neuronal cell death occurs by two mechanisms: necrosis and apoptosis. Apoptosis is a process whereby developmental cues and environmental stimuli activate a genetic program to implement a series of steps that culminate in cell death. An important aspect of apoptosis is that it can be halted and such interventions may rescue dying neurons. The overall goal of this project is to identify key protein kinases that regulate neuronal survival and apoptosis. The aims, as described in the Statement of Work, are to: 1) Define key protein kinase cascades regulated by neurotrophic factors, 2) Modulate the protein kinase cascades regulated by neurotrophic factors and determine the consequence on neuronal survival and death, and 3) Examine the cross-talk between pro-apoptotic and anti-apoptotic protein kinase pathways. Our key research accomplishments over the last year lie in several areas. One is identifying transcription factors downstream of the protein kinases that regulate neuronal survival and death. The second area is defining the role of Rho/Rac GTPases in regulating neuronal cell death. The third area is understanding how various pathways known to regulate neuronal apoptosis operate together to direct the fate of neurons. The progress made in these areas has resulted in 4 manuscripts (1 article under revision) and 8 abstracts presented at national and international meetings this past year.
INTRODUCTION
Loss of post-mitotic neurons from the adult brain underlies the pathology of neurodegenerative diseases and neurotoxin exposure. Neuronal cell death occurs by two mechanisms: necrosis and apoptosis. Apoptosis is a process whereby developmental cues and environmental stimuli activate a genetic program to implement a series of steps that culminate in cell death. An important aspect of apoptosis is that it can be halted and such interventions may rescue dying neurons. The overall goal of this project is to identify key protein kinases involved in regulating neuronal survival and apoptosis. The aims for the this year of funding as described in the Statement of Work were to: 1) Continue studies on protein kinase cascades that regulate neuronal survival, 2) Modulate the protein kinase cascades regulated by neurotrophic factors and determine the consequence on neuronal survival and death, and 3) Begin studies examining the cross-talk in pro-apoptotic and anti-apoptotic protein kinase signaling cascades. The progress made in these areas, described below, has resulted in 4 published manuscripts (plus 1 article under revision) and 8 abstracts presented at national and international scientific meetings.
Task #1. The first task is to identify protein kinase cascades that regulate neuronal survival.
As described in our progress report last year, we have identified a number of protein kinase cascades that either inhibit or initiate neuronal apoptosis. This year we have extended those previous studies by identifying a transcription factor downstream of a calcium-regulated protein kinase/phosphatase pathway that controls neuronal survival. The results of these studies have been published in the Journal of Neuroscience this year and are described in the attached Appendix #1.
We have also examined the role of upstream Rho/Rac GTPases in neuronal survival. We have shown that inhibition of Rac/Cdc42 function induces apoptosis of cerebellar granule neurons via a c-jun signaling pathway. These results were published in the Journal of Biological Chemistry and are described in Appendix #2. Task #2 The second task is to determine whether activation or inhibition of the neurotrophin-regulated kinases is necessary or sufficient to influence neuronal survival.
Over the last year we finished up work demonstrating that inhibitors of p38 MAP kinase, a protein kinase activated when neurons die by apoptosis, increase the survival of transplanted dopamine neurons. Fetal cell transplantation therapies are being developed for the treatment of a Heidenreich, KA number of neurodegenerative disorders including Parkinson's disease. Massive apoptotic cell death is a major limiting factor for the success of neurotransplantation. We showed that inhibitors of stress-activated protein kinases improve the outcome of cell transplantation by preventing apoptosis of neurons after grafting. These inhibitors offer advantages over other approaches to block neuronal apoptosis because they are small organic molecules that are orally active and cross the blood-brain barrier. These results were published in Brain Research this year (Appendix#3).
In collaboration with Dr. Curt Freed, we completed studies on the effects of growth factors on survival of human dopamine neurons transplanted into Parkinsonian rats. We showed that in vitro preincubation of human fetal tissue strands with IGF-I and bFGF improves dopamine cell survival and the behavioral outcome of transplants. These results were published in Experimental Neurology and are described in more detail in Appendix #4. Task #3 The third task is to determine whether there is cross-talk between pro-apoptotic and anti-apoptotic signaling pathways.
We have recently discovered that convergence of glycogen synthase kinase-3ß and c-jun pro-apoptotic signals appear to be required upstream of myocyte enhancer factor 2D degradation during neuronal apoptosis. Cerebellar granule neurons undergo apoptosis when deprived of serum and depolarizing K + . The pro-survival transcription factor, myocyte enhancer factor 2D (MEF2D), is rapidly hyperphosphorylated and cleaved by caspases in apoptotic cerebellar granule neurons. MEF2D degradation occurs prior to activation of the executioner caspase-3, and therefore, may play a critical role in the commitment of cerebellar granule neurons to apoptosis. We also know that the pro-apoptotic proteins, GSK-3 ß and c-Jun turn on apoptosis in granule neurons, however, the precise targets of their action are currently unknown. Over the last year, we investigated whether either GSK-3 ß or c-Jun facilitate MEF2D processing during apoptosis. We utilized the neurotrophin, insulin-like growth factor-I (IGF-I), to selectively inhibit GSK-3 ß activation, and the p38/JNK inhibitor, SB203580, to selectively block c-Jun induction. Neither IGF-I nor SB203580 had any significant effect on MEF2D hyperphosphorylation, the decreased DNA binding of MEF2 proteins, or the initial loss of MEF2-dependent transcriptional activity observed in trophic factor-deprived CGNs. However, incubation with either IGF-I or SB203580 significantly blocked degradation of MEF2D and the corresponding formation of a NH2-terminal truncated MEF2 fragment that has previously been shown to act as a dominant-negative transcription factor. Moreover, inclusion of either IGF-I or Heidenreich, KA SB203580 during acute trophic factor withdrawal significantly enhanced recovery of MEF2-dependent transcriptional activity in cerebellar granule neurons following the re-addition of depolarizing K + . The results demonstrate that GSK-3ß and c-Jun are both required upstream of MEF2D degradation, suggesting that these pro-apoptotic molecules act in a coordinated manner very early in the apoptotic cascade. This work will be presented at the Society for Neuroscience meetings in November 2001 (Appendix #5).
Another area that we've made progress in is understanding how neurotrophin signaling pathways impact on the intrinsic death machinery in neurons. Over the last year, we identified the intrinsic (mitochondrial) death pathway as a principal target of IGF-I action. In cerebellar granule neurons undergoing apoptosis, IGF-I blocked activation of both the executioner caspase-3 and the mitochondrial-dependent initiator caspase-9. Upstream of caspase-9, IGF-I inhibited redistribution of cytochrome C from mitochondria to focal complexes localized in neuronal processes. IGF-I had no effect on mitochondrial swelling or mitochondrial membrane depolarization, but significantly attenuated induction of the pro-apoptotic Bcl-2 family member Bim. Although the transcription factor c-Jun has previously been shown to regulate Bim, IGF-I failed to block c-Jun phosphorylation in trophic factor-deprived granule neurons. In contrast, IGF-I significantly inhibited dephosphorylation and nuclear localization of the forkhead transcription factor (FKHR), suggesting a role for FKHR in the regulation of Bim expression.
Moreover, Bim induction, cytochrome C release and caspase activation were blocked by cycloheximide, indicating that de novo synthesis of Bim is required for apoptosis. Thus, IGF-I rescues cerebellar granule neurons from apoptosis by blocking intrinsic death signaling at the level of FKHR regulation of Bim. A manuscript describing thes results in under preparation.
KEY RESEARCH ACCOMPLISHMENTS
Our key research accomplishments over the last year lie in several areas. One is defining transcription factors downstream of identified protein kinases that regulate neuronal survival and death. We have also opened up a relatively new area of investigation examining the role of Rho/Rac GTPases (upstream of protein kinases)in regulating neuronal cell death. The third area is understanding how various pathways known to regulate neuronal apoptosis operate together to direct the fate of neurons.
Heidenreich, KA Myocyte enhancer factor 2 (MEF2) transcription factors are members of the MADS (MCMl-agamous-deficiens-serum response factor) family of transcription factors (Yu et al., 1992; Naya and Olson, 1999) . A hallmark of MADS-box proteins is their combinational association with other MADS domain factors, as well as other heterologous classes of transcriptional regulators (Shore and Sharrocks, 1995) . Mammalian MEF2 proteins are encoded by four genes (MEF2A, MEF2B, MEF2C, and MEF2D), each of which gives rise to alternatively spliced transcripts (Yu et al, 1992; Leiter et al., 1993; Martin et al, 1994 ). The MEF2 family of genes is highly expressed in cells of muscle lineage, where they have been shown to be important regulators of gene expression during the development of skeletal, cardiac, and smooth muscle (McDermott et al, 1993; Martin et al., 1994; . In these tissues the MEF2 proteins interact with myogenic basic helix-loop-helix transcription factors such as MyoD to activate myogenesis Ornatsky et al, 1997 ).
REPORT ABLE OUTCOMES
AU MEF2 family members also are highly expressed in neurons of the CNS (Leiter et al, 1993 (Leiter et al, , 1994 McDermott et al., 1993; Ikeshima et al, 1995; Lyons et al, 1995; . Recent in vitro findings support the hypothesis that MEF2 transcription factors regulate neuronal survival and development. In cultures of cerebral cortical neurons in which proliferating precursor cells and postmitotic differentiating neurons can be distinguished, MEF2C is expressed selectively in newly generated postmitotic neurons and is not detectable in BrdU-positive precursor cells . Transfection of postmitotic cortical neurons with different MEF2C mutants demonstrated that MEF2C is required for the survival of these neurons. In postnatal day 19 (P19) neuronal precursor cells, the expression of MEF2 induces a mixed neuronal/myogenic phenotype (Okamoto et al., 2000) . During retinoic acid-induced neurogenesis of these cells, a dominant-negative form of MEF2C enhances apoptosis but does not affect cell division. On the other hand, P19 cells induced to undergo apoptosis can be rescued from cell death by the expression of constitutively active MEF2C. In addition, overexpression of MEF2C in P19 cells results in induction of neurofilament protein, the nuclear antigen NeuN, and MASH-1, a neuralspecific transcription factor known to interact with MEF2s (Skerjanc and Wilton, 2000) . These data suggest that MEF2 proteins regulate neuronal development by promoting survival and inducing differentiation.
In the present study we examined the mechanisms regulating the activity of MEF2 proteins during apoptosis of cultured rat cerebellar granule neurons, a well established model of depolarization-dependent neuronal survival. We provide evidence that MEF2A and MEF2D are prosurvival factors with high DNA binding and transcriptional activity in postmitotic cerebellar granule neurons. When these neurons are induced to undergo apoptosis by lowering extracellular potassium, MEF2A and MEF2D are phosphorylated. The phosphorylation of MEF2D and MEF2A is followed by decreased DNA binding and cleavage by a caspase-sensitive pathway to N-terminal MEF2 fragments that lack the transactivation domain. The decreased DNA binding of MEF2s and the formation of MEF2 fragments that can act as dominant-inactive transcription factors are sufficient to block the prosurvival effects of MEF2s and induce apoptosis in mature cerebellar granule neurons.
MATERIALS AND METHODS
Materials. The MEF2A antibody is an affinity-purified rabbit polyclonal antibody that was raised to a peptide corresponding to codons 487-507 of human MEF2A purchased from Santa Cruz Biotechnology (Santa Cruz. CA). According to the manufacturer, this antibody may cross-react to a small extent with MEF2C. The affinity-purified rabbit polyclonal MEF2C antibody, a gift from John Schwarz (University of Texas Medical School, Houston, TX), was raised against an isoform-specific peptide representing codons 300-316 of human MEF2C and is specific for MEF2C . The rabbit polyclonal antibody to MEF2B was raised against a polyhistidine fusion protein corresponding to codons 234-365 of human MEF2B and was kindly provided by Dr. Ron Prywes (Columbia University, NY). Antibody to MEF2D is a monoclonal antibody raised against a peptide corresponding to codons 346-511 of mouse MEF2D purchased from Transduction Laboratories (Lexington, KY). The dominant-inactive MEF2 mutant pcDNA3-MEF2A131 was kindly provided by Dr. Prywes. The dominant-active MEF2 mutant pCMV-MEF2D-VP16 was a gift from Dr. John C. McDcrmott (York University, Toronto, Ontario, Canada). The pGL2-MEF2-Luc reporter plasmid (Lemercier et al., 2000) was provided by Dr. Saadi Khochhin (INSERM, France). The caspase-3 antibody was purchased from Santa Cruz Biotechnology, and the polyclonal anti-ß-galactosidasc (ß-gal) antibody was purchased from 5 Prime^>3 Prime (Boulder, CO). Cy3-conjugated goat antibody to rabbit IgG was purchased from Chemicon (Tcmccula, CA). The caspase inhibitors YVAD-CHO, DEVD-FMK, and ZVAD-FMK were obtained from Calbiochem (La Jolla, CA). [a-
32 P]CTP (3000 Ci/mmol) was purchased from Amersham Pharmacia Biotechnology (Piscataway, NJ).
Neuronal cell culture. Rat cerebellar granule neurons were prepared from 7-to 8-d-old Sprague Dawlcy rat pups (15-19 gm) as described previously (Li et al., 2000) . Briefly, neurons were seeded at a density of 2.0 X 10 6 cells/ml in basal modified Eagle's (BME) medium containing 10% fetal bovine serum, 25 mM KC1, 2 IHM glutaminc, and penicillin (100 U/ml)/strcptomycin (100 /xg/ml). Cytosinc arabinoside (10 (IM) was added to the culture medium 24 hr after plating to limit the growth of non-neuronal cells. With the use of this protocol, 95-99% of the cultured cells were granule neurons. Transfcctions were performed at day 5-6 in culture, and experiments were performed after 7 d in culture. Apoptosis was induced by removing the scrum and reducing the extracellular potassium concentration from 25 to 5 mM. Control cultures were treated identically but were maintained in serum-free medium supplemented with 25 mM KC1.
Western blot analysis. Western blot analysis was performed as described previously (Li et al., 2000) . Briefly, neurons were lyscd by adding SDS sample buffer [62.5 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 109? glycerol, 50 mM DTT, and 0.1% (w/v) bromphenol blue]. The samples were resolved by SDS-PAGE with the use of either 7.5 or 12% acrylamidc gels, as indicated in the legends. Proteins were transferred to Hybond-P membranes (polyvinylidenc difluoridc). The membranes were incubated with anti-MEF2A (1:5000), anti-MEF2D (1:1000), anti-MEF2C (1:1000), and anti-MEF2B (1:500). After incubation with the primary antibodies the filters were washed and then incubated with the respective horseradish pcroxidase (HRP)-conjugatcd anti-rabbit or anti-mouse antibody (Amersham Pharmacia Biotech). Then the blots were washed and subsequently were developed with an enhanced chcmiluminescence system (Amersham Pharmacia Biotech) and exposed to Kodak autoradiographic film. Quantitation was performed with the Bio-Rad Quantity One software (Hercules, CA).
Preparation of nuclear extracts from cerebellar granule neurons. After 7 d in culture the cerebellar granule neurons were rinsed two times in serum-free BME containing 25 mM KC1 and then maintained in 25 or 5 mM KC1 medium in the absence or presence of caspase inhibitors. Neurons that did not receive inhibitors received the control vehicle dimethyl sulfoxidc (DMSO). After the indicated times the neurons (100 mm dishes) were washed with ice-cold PBS and detached from culture dishes by a cell scraper in 0.5 ml of buffer A [0.25 M sucrose and (in mM) 15 Tris. pH 7.9, 60 KCI, 2 EDTA, pH 8.0, 0.5 EGTA, 15 NaCl, 1.0 Na,V0 4 . 50 NaF, 0.5 spcrmidinc, 1 DTT, 1 benzamidinc, and 0.5 PMSF plus 20 /ng/ml leupeptin, 0.76 /xg/ml pepstatin, and 2 ßM aprotinin]. The cells were ccntrifuged at 250 x g for 5 min. The pellets were washed twice in buffer A and then homogenized with 15 strokes of a tight-fitting Dounce homogenizcr to release the nuclei. Then the homogenate was ccntrifuged at 14,000 x g for 15 sec to pellet the nuclei. The supcrnatants were removed, and the pellets were resuspended in buffer C [(in mM) 20 HEPES, pH 7.9, 500 KCI, 1.5 MgCI,, 1 EDTA, pH 8.0, 1.0 Na 1 V0 4 50 NaF, 1.0 DTT, 1 benzamidinc, and 5.5 PMSF plus 20 /ng/ml leupeptin, 0.76 ng/m! pepstatin, 25% glycerol, and 10 IJLM aprotinin]. Nuclear proteins were extracted at 4°C for 45 min, and insoluble nuclei were precipitated by ccntrifugation at 14000 X g for 15 min. Supcrnatants were dialyzed against a buffer containing 10% glycerol and (in mM) 10 Tris, pH 7.9, 5 MgCL, 50 KCI, I EDTA, pH 8.0, 1.0 Na 3 V0 4 , 50 NaF, 1 DTT, 1 PMSF, and 1 benzamidinc for 3 hr at 4°C. The extracts were quantified for protein content by the BCA method (Pierce, Rockford, IL) and frozen in small aliquots at -70°C.
Electrophoretic mobility shift assays. Nuclear extracts from cerebellar granule neurons (10 jug) were incubated with double-stranded oligonuclcotidcs corresponding to the muscle creatinc kinasc MEF2 site 5'-CGGATCGCTCTAAA/1ATAACCCTGTCG-3' (Amacher ct al" 1993) or to a mutant oligonucleotidc containing C^G and A^C substitutions at the two italicized residues. The oligomcrs were end-labeled with the Klenow fragment of DNA polymerase I (Life Technologies, Gaithcrsburg. MD) and [a- 32 P]CTP to a specific activity of 10,000-30,000 cpm/ ng. Binding reactions were performed for 20 min at 4°C in 1 mM dithiothrcitol, 2.5 mM MgCL, 10% glycerol, 0.1 mg/ml bovine scrum albumin, 30 ng/ud of poly(dbdC), 20 mM HEPES, pH 7.9, and 50-100,000 cpm of oligomcr in a total volume of 20 fx\. For the supcrshift analysis. 1 fx\ of specific antiscra or preimmunc scrum was added to the nuclear extracts for 20 min at 4°C, followed by another 20 min in the presence of labeled oligomcrs. The protcin-DNA complexes were analyzed on 5% nondenaturing polyacrylamidc gels containing 3% glycerol and 0.25x TBE (90 M Tris boratc, 1 mM EDTA) in the cold room. After electrophorcsis the gels were dried and exposed to film at -70°C.
Transfection assays and reporter gene expression. Cerebellar granule neurons were transfectcd by a calcium phosphate coprecipitation method described previously (Li et al., 2000) . Neurons were transfectcd with 1 fig of MEF2-luciferase expression plasmids (pGL2-MEF2-luc) and/or 1-3 lig of MEF2D expression plasmids (pCMV-MEF2D-VP16, pcDNA3-MEF2A131) and 1 /xg of pCMV-ß-gal as an internal control for transfection efficiency. The total amount of DNA for each transfection was kept constant (7 /xg/ m ') by using the empty vector pcDNA3. Neurons were kept in conditioned medium after transfection for 2 hr; then the medium was replaced with BME containing 25 or 5 mM KCI. After 4 hr the cell extracts were prepared with reporter lysis buffer (Promcga, Madison, WI), and the activities of lucifcrasc and ß-galactosidasc were measured with the Lucifcrasc Assay System (Promcga) and the ß-galactosidase Enzyme Assay System (Promcga), respectively.
Quantitation of apoptosis in transfectcd neurons. Neurons were transfectcd as described previously (Li et al., 2000) . Plasmids (pCMV-MEF2D-VP16, pCMV-MEF2D-VP16 plus pcDNA3-MEF2A131, and pCMV-LacZ) were added to the transfection media at a final concentration of 4-5 Hg/ml. The total amount of DNA for each transfection was kept constant by using the empty vector pcDNA3. After transfection the neurons were switched to a medium containing 25 or 5 mM KCI. Then 16 hr later the cells were immunostaincd with a polyclonal antibody to ß-galactosidasc (1:500 dilution), followed by a Cy3-conjugatcd goat antibody to rabbit IgG (1:500) to identify cells expressing ß-galactosidasc. To visualize the nuclei of transfectcd neurons, we included the DNA dye Hoechst 33258 (5.0 /ng/ml) in the wash after the secondary antibody incubation. Apoptosis was quantified by scoring the percentage of cells in the ß-galactosidasc-expressing cell population with condensed or fragmented nuclei. So that wc could obtain unbiased counting, cells (-500)
RESULTS

MEF2
protein expression and phosphorylation state in control and apoptotic cerebellar granule neurons Primary cerebellar granule neurons represent a widely used in vitro model system that mimics the trophic action of neuronal activity that is seen in the developing nervous system (D' Mello et al., 1993; Miller et al., 1997) . Thus, elevated levels of extracellular potassium promote neuronal survival by opening L-type voltagesensitive calcium channels, leading to an influx of calcium into neurons. Lowering of extracellular potassium decreases calcium influx and promotes neuronal cell death by an apoptotic mechanism.
Western analysis indicated that all four members of the MEF2 superfamily of transcription factors were present in cerebellar granule cells (Fig. 1A) . When neurons were induced to undergo apoptosis by lowering extracellular potassium, there were selective shifts in the mobility of MEF2A (Fig. \A, top) and MEF2D (Fig. \A, bottom) on SDS gels. The mobility shifts were detected in neuronal cell lysates as early as 30 min and sustained to 8 hr. The shifts in mobility of MEF2A and MEF2D were enhanced when the samples were electrophoresed for longer times through higher resolution gels (Fig. 15) . Treatment of neuronal protein extracts with calf intestinal alkaline phosphatase before electrophoresis reversed the mobility shift of MEF2A and MEF2D seen in the low potassium conditions, confirming that the shifts in mobility of MEF2A and MEF2D were attributable to enhanced serine/threonine phosphorylation (Fig. 1C) . The phosphorylation sites responsible for the increase in phosphorylation seen on lowering intracellular calcium are functionally different from those previously reported to enhance transcription. Both a p38 inhibitor (10 /AM SB203580) and a MEK inhibitor (10 /AM PD98059) failed to block the increase in phosphorylation seen with the induction of apoptosis (data not shown). The relative intensities of the slower-migrating MEF2A and MEF2D proteins decreased after 4 and 8 hr in low potassium medium (Fig. 1A,  lanes 6, 8) , whereas the faster-migrating MEF2 proteins observed under depolarizing conditions remained constant, suggesting a link between MEF2 phosphorylation and degradation.
MEF2D transcriptional activity is regulated by extracellular potassium
The transcriptional activity of MEF2 proteins in cerebellar granule neurons was measured with a luciferase reporter plasmid that contains two MEF2 consensus sites, followed by the luciferase reporter gene (Lemercier et al., 2000) . Cerebellar granule neurons grown in the presence of depolarizing potassium (25 IHM) demonstrated high endogenous MEF2-driven luciferase activity ( Fig. 2A) . After the potassium was lowered to 5 ITIM for 4-8 hr, the transcriptional activity of the MEF2 reporter was decreased by -90% (p < 0.05) (Figure 2A) . Incubation in 5 mM potassium for 4 hr, followed by the readdition of 25 mM potassium for an additional 4 hr, restored -50% of the MEF2 transcriptional activity ( Fig. 2A) . Similarly, the readdition of 25 mM potassium also reversed the mobility shift in MEF2D (Fig. 2B) , suggesting that phosphorylation of MEF2D during apoptosis is associated with the observed decrease in MEF2 transcriptional activity. The fact that only a partial recovery of MEF2-driven luciferase activity was observed in the above experiment could be accounted for by the significant degradation of MEF2D that had occurred after A. Figure 2 . Neurons switched to 5 mM KCl show enhanced MEF2D phosphorylation and decreased MEF2 transcriptional activity; the rcaddition of 25 mM KCl promotes the dephosphorylation of MEF2D and the partial recovery of MEF2 transcriptional activity. A, Cercbcllar granule neurons (day 6) were transfected with a MEF2-rcsponsivc lucifcrasc reporter and pCMV-j3-gal. After transfection (2 hr) the neurons were placed in serum-free medium containing either 25 or 5 mM KCl for 8 hr.
In addition, some cells were incubated for 4 hr in 5 mM KCl, followed by the readdition of 25 mM KCl for an additional 4 hr. Then lucifcrasc and ß-galactosidase activities were determined as described in Materials and Methods. B, Cerebellar granule neurons were incubated as described in A, and the phosphorylation status and relative quantity of MEF2D were determined by immunoblot (IB) analysis. C, Cerebellar granule neurons were transfected with a MEF2-rcsponsive lucifcrasc reporter and pCM V-ß-gal in the absence or presence of pCMV-MEF2D-VPl6. After 4 hr the luciferase and j3-galactosidasc activities were determined. Data arc expressed as a percentage of control neurons grown in 25 niM KCl and arc the mean ± SEM (n = 3). Figure 3 . MEF2 DNA binding activity is decreased in apoptotic neurons. Cercbcllar granule neurons (day 7) were placed in scrum-free medium containing 25 or 5 mM KCl. After the indicated times, nuclear extracts were prepared, and gel mobility shift assays were performed with a double-stranded '^P-labeled consensus (wt) or mutant (nun) MEF2 oligomcr. NS, Nonspecific protein/DNA complex; HMC, high-mobility complex; LMC, low-mobility complex.
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4 hr in 5 mM potassium (Fig. 2ß, lane 1 vs lane 3) . Finally, transfection of neurons with MEF2D-VP16, a constitutivcly active mutant of MEF2D, attenuated the decline of MEF2 luciferase activity during potassium withdrawal (Fig. 2C) . The decrease in MEF2 transcriptional activity was not attributable to a nonselcctivc effect of cell death, because the transcriptional activity of AP-1 measured with an AP-1 luciferase reporter construct was increased by 30% under the same conditions by which the MEF2 transcriptional activity decreased (data not shown).
DNA binding of MEF2A and MEF2D is regulated by extracellular potassium
To determine whether the DNA binding activity of MEF2 proteins was regulated during induction of the apoptosis of cerebellar granule neurons, we performed electrophorctic mobility shift assays (EMSAs) by using wild-type and mutant MEF2 doublestranded oligonucleotides. Nuclear extracts from cerebellar granule neurons cultured in medium containing 25 mM KCl demonstrated one specific high-mobility protcin-DNA complex, HMC (Fig. 3) . Extracts from neurons cultured in 5 mM KCl revealed a decrease in the HMC that was detected as early as 2 hr after the potassium was lowered. In addition to the decrease in the HMC associated with the apoptotic response, a new lower-mobility MEF2-DNA binding complex, LMC, was detected in extracts were placed in serum-free medium containing 25 or 5 mM KCl. After 4 hr, nuclear extracts were prepared, and supershift gel mobility shift assays were performed with a double-stranded 32 P-labeled consensus MEF2 oligomer in the absence or presence of MEF2 antibodies. Note that the lower-molecular-weight complex did not shift with MEF2 antibodies. SSB, Supershifted band; HMC, high-mobility complex; LMC, low-mobility complex; NS, nonspecific protein/DNA complex. isolated 4 and 6 hr after the media change. Neither the HMC nor the LMC was detected by using a mutant MEF2 oligonucleotide.
EMSAs that used antibodies against MEF2A, B, C, and D proteins were performed to determine which MEF2 proteins were bound to DNA under control and apoptotic conditions (Fig.  4) . In control neurons, antibodies against MEF2A and MEF2D shifted the HMC to a slower migrating band (SSB), whereas antibodies against MEF2B and MEF2C had little effect on the MEF2-DNA complex. Similar results were obtained in apoptotic neurons, although the amount of high-mobility complex was significantly lower than that present in healthy neurons. Interestingly, the LMC was not shifted by any of the MEF2 antibodies. Because each of the antibodies was raised against the C terminus, but not the N terminus DNA binding domain of MEF2 proteins (Fig. 5^4) , we questioned whether MEF2A and MEF2D were degraded during apoptosis to yield MEF2 fragments that bound DNA but did not interact with the antibodies.
Degradation of MEF2A and MEF2D during apoptosis of cerebellar granule neurons To test the hypothesis that MEF2 proteins were degraded during apoptosis, we performed Western analysis and exposed the transferred proteins to film for longer periods of time than in previous experiments. The results showed that, within 1 hr of inducing apoptosis, MEF2D was phosphorylated, as shown previously, and a smaller-molecular-weight MEF2D fragment appeared (Fig.  55) . The fragment, usually a broad band, had an apparent molecular weight of 40-45 kDa, -15 kDa less than full-length MEF2D. Figure 5 . MEF2D is cleaved by a caspase-mediated pathway during apoptosis. A, Domain structure of the MEF2 proteins, including the MEF2A and MEF2D antibody recognition motifs and the putative caspase cleavage region. B, Cerebellar granule neurons (day 7) were placed in serum-free medium containing 25 or 5 mM KCl. At the indicated times, Western analysis was performed with 12% SDS-acrylamide gels and specific MEF2D antibodies. C, Neurons were placed in serum-free medium containing 25 or 5 mM KCl (4 hr) in the absence or presence of various concentrations of the caspase-3-specific inhibitor DEVD or the pan-caspase inhibitor Z-VAD. Brackets indicate a lower-molecular-weight cleavage product recognized by the C-terminal MEF2D antibody.
Analysis of various MEF2 sequences (rat MEF2D and mouse MEF2Dla and MEF2A) revealed several putative caspase cleavage sites (DXXD) between the DNA binding domain and the antibody recognition domain (amino acids 100-346) (Fig. 5^4) . To determine whether the MEF2 fragment that was generated during apoptosis resulted from caspase cleavage, we performed experiments to assess whether caspase inhibitors blocked formation of the MEF2D fragment. DEVD, a caspase-3-specific inhibitor, and Z-VAD, a nonselective caspase inhibitor, blocked the formation of the MEF2D fragment in a dose-dependent manner (Fig.  5C ). Z-VAD was much more effective and potent than DEVD in preventing cleavage of MEF2D, suggesting that an upstream caspase rather than the downstream caspase-3 might be involved in cleaving MEF2D. Consistent with this idea was the finding that the cleavage of MEF2D occurred much earlier than the activation HMC-Z-VAD Figure 6 . Caspase-3 activation in rat ccrcbellar granule neurons. Cercbellar granule neurons (day 7) were placed in serum-free medium containing 25 or 5 itiM potassium. At the indicated times, Western analysis was performed with 15% SDS-acrylamide gels and an antibody that detects pro-caspase-3 and an active caspase-3 cleavage product.
of caspase-3, which was maximal at 5-6 hr after the induction of apoptosis (Fig. 6 ).
Caspase inhibitor blocks formation of the low-mobility protein-DNA complex Blockade of MEF2D cleavage by caspase inhibitors supported the hypothesis that during apoptosis MEF2D is cleaved to generate a N-terminal DNA binding fragment, which is not recognized by antibodies directed against the regulatory domain, and a C-terminal fragment that is recognized by Western blotting. To test this hypothesis directly, we treated neurons with and without a caspase inhibitor before the EMSAs (Fig. 7) . As shown previously in nuclear extracts from control neurons grown in 25 IHM KC1, the LMC was very low (Fig. 7, lane 1) . After 4 hr of apoptosis induced by lowering the extracellular potassium to 5 mM, the LMC was abundant (Fig. 7, lane 2) . The caspase inhibitor Z-VAD, added at the time of the medium change, prevented the formation of the lower-molecular-weight complex (Fig. 7, lane 3) . In addition, DVED and YVAD (a caspase-1-selective inhibitor) were only partially effective at inhibiting the formation of the low-molecular-weight complex (data not shown). Together, these data suggest that MEF2D and MEF2A are cleaved by a caspasesensitive pathway to generate N-terminal fragments that bind to DNA but are not recognized by antibodies directed to the C terminus of each of these proteins. Figure 7 . Formation of the lowcr-molccular-wcight protein/DNA binding complex is prevented by caspase inhibition. Cercbcllar granule neurons (day 7) were placed in serum-free medium containing 25 or 5 mM KC1 in the absence or presence of 100/MM pan-caspase inhibitor (Z-VAD). After 4 hr, nuclear extracts were prepared, and gel mobility shift assays were performed with a double-stranded "P-labcled consensus MEF2 oligomcr. HMC, High-mobility complex; LMC, low-mobility complex; NS, nonspecific protein/DNA complex.
two expression plasmids, transcriptional activity was determined with the MEF2 luciferase reporter plasmid ( Fig. 8/1 ). As observed previously, neurons incubated in 5 mM potassium had low MEF2 transcriptional activity. However, the expression of a constitutively active mutant of MEF2D (MEF2D-VP16) maintained high MEF2 transcriptional activity even in the presence of 5 mM potassium. When the VP16 mutant of MEF2D (1 /xg) was expressed in the presence of increasing concentrations of truncated MEF2A131 (1-3 jag of DNA), the N-terminal MEF2 fragment blocked MEF2 luciferase activity in a dose-dependent manner ( Fig. 8/1 ). These data indicate that a truncated MEF2 can block the DNA binding and activity of MEF2 competitively. The consequence of the expression of truncated MEF2 on neuronal apoptosis is seen in Figure 8S . In these experiments, neurons were transfected with the control vector, MEF2D-VP16, or MEF2D-VP16 in the presence of increasing amounts of trun- Figure 8 . The N terminus of MEF2 antagonizes MEF2 activity and MEF2-mediated neuronal survival. ,4, Cerebellar granule neurons (day 6) were transfected with a MEF2-responsive luciferase reporter and pCM Vj3-gal in the absence or presence of 1 /xg of MEF2D-VP16 and MEF2A131 (1-3 /ig). After transfection (2 hr) the neurons were placed in serum-free medium containing 5 mM KC1. After 4 hr, luciferase and ß-galactosidase activities were determined. Luciferase activity was normalized with respect to that of ß-galactosidase. Data are expressed as percentage of control neurons grown in 25 mM potassium. Data are the mean ± SEM (n = 3). B, Cerebellar granule neurons (day 5) were cotransfected with pCMV-ß-gal and the indicated expression vector at the concentrations given in A. After transfection the neurons were placed in serum-free medium containing 5 mM KC1 for 16 hr and then fixed and immunostained with a ß-gal antibody. The neurons also were stained with Hoechst 33258. Apoptosis was quantified by scoring the percentage of transfected neurons with condensed or fragmented nuclei. Data are the mean ± SEM (n = 3). Vector, Empty pcDNA vector. cated MEF2A131. In neurons maintained in 5 mM potassium for 16 hr the level of apoptosis was 56%. Transfection of the neurons with MEF2D-VP16 reduced the amount of apoptosis to -22%. When the truncated MEF2A131 mutant (1-3 jag of DNA) was introduced with MEF2D-VP16 into neurons, the ability of MEF2D-VP16 to block apoptosis was attenuated in a dosedependent manner. These data indicate that the MEF2 N-terminal fragment can act as a dominant-negative transcription factor and antagonize the prosurvival function of MEF2D. . At 14 weeks of gestation, MEF2C immunoreactivity is present in cell nuclei throughout the cortical plate. Subsequently, MEF2C immunoreactivity develops a bilaminate and then a trilaminate distribution and ultimately is expressed preferentially in layers II, IV, and VI of mature neocortex (Leifer et al, 1994) . These findings suggest a role for MEF2C in postmitotic neuronal differentiation, in particular in the development of certain cortical layers.
DISCUSSION
In the cerebellum, MEF2A and MEF2D mRNA levels dramatically increase at ~P9, reach a peak at P15-P18, and stay high in adults (Leifer et al, 1994; Ikeshima et al, 1995; Lin et al, 1996; Mao and Wiedmann, 1999) . This time course of MEF2 expression coincides with the expression of the GABA A receptor a6 subunit mRNA, a marker for the differentiation of mature cerebellar granule neurons. Immunohistochemical staining reveals that MEF2 protein expression occurs primarily in the internal granule cell layer of the cerebellum (Ikeshima et al, 1995) . During postnatal development, differentiated granule neurons generated in the external germinal layer migrate to the internal granule layer where they are innervated by mossy fiber axons. There is considerable loss of granule neurons during this process and it is thought that the survival of granule neurons is regulated by depolarization-induced mechanisms during this time period.
Postmitotic granule neurons derived from neonatal rat can be maintained readily in vitro in their fully differentiated state if they are depolarized with a high extracellular concentration of potassium (D'Mello et al, 1993 ; Miller et al, 1997) . If the extracellular potassium concentration is reduced, granule neurons undergo programmed cell death with classic morphological and biochemical features of apoptosis. These characteristics, along with the abundance and high degree of homogeneity, make cultured granule neurons an excellent model to examine the role of MEF2 proteins in depolarization-dependent neuronal survival.
In this report we have defined a novel mechanism by which the activity and levels of MEF2 proteins are regulated during apoptosis of cerebellar granule neurons. We also have shown that MEF2 proteins are regulated in an isotype-specific manner. All four MEF2 isoforms (A, B, C, and D) were detected by immunoblot analysis in rat cerebellar granule neurons. However, in agreement with results from immunocytochemistry and in situ hybridization (Ikeshima et al, 1995; Lyons et al, 1995) , MEF2A and MEF2D were the most prominent MEF2 proteins detected in the cultured cerebellar granule neurons when equal amounts of total protein were analyzed by Westerns (data not shown). MEF2A and MEF2D appear to be responsible for most, if not all, of the MEF2 DNA binding activity in viable cerebellar granule neurons. When granule neurons are induced to undergo apoptosis by lowering potassium, endogenous MEF2A and MEF2D, but not MEF2B and MEF2C, are phosphorylated. Phosphorylation is accompanied by a decrease in MEF2 transcriptional activity, and both effects are reversed by the readdition of depolarizing potas- Figure 9 . The regulation of MEF2 proteins during apoptosis of rat cerebellar granule neurons. When granule neurons are induced to undergo apoptosis by lowering extracellular potassium to 5 IHM, endogenous MEF2D and MEF2A (data not shown) arc phosphorylated. Phosphorylation of MEF2D induced by decreasing calcium influx not only leads to decreased DNA binding but also is associated with a caspase-dependent cleavage of MEF2D. The caspasc involved in cleaving MEF2D remains to be identified. The cleavage of MEF2D results in an N-terminal fragment (-100 amino acids long) that retains its DNA binding capacity, is not recognized by C-terminal antibodies, and lacks the transactivation domain. The MEF2 N-terminal fragment is capable of blocking the activity of MEF2D, thus acting as a dominant-negative transcription factor. The decline in MEF2 activity because of decreased DNA binding and formation of a dominant-inactive MEF2 fragment leads to apoptosis.
sium. The most novel findings of the present study show that the phosphorylation of MEF2D that is induced by decreasing calcium influx not only correlates with decreased DNA binding but also is associated with a direct or indirect caspase-dependent cleavage of MEF2D (Fig. 9 ). The cleavage of MEF2D results in a N-terminal fragment (-100 amino acids long) that retains its DNA binding capacity, is not recognized by C-terminal antibodies, and lacks the transactivation domain. The MEF2 N-terminal fragment is capable of blocking the activity of MEF2D, thus acting as a dominant-negative transcription factor. The decline in MEF2 activity resulting from decreased DNA binding and formation of a dominant-inactive MEF2 fragment appears to be sufficient to mediate execution of the apoptotic process. Overexpression of a constitutively active MEF2D that does not get cleaved prevents the loss in MEF2 transcriptional activity during apoptosis and protects against apoptosis that is induced by lowering membrane depolarization and calcium influx.
The signaling pathways responsible for the changes in the phosphorylation state of MEF2 could involve an increase in the activity of a calcium-sensitive kinase, a decrease in the activity of a calcium-sensitive phosphatase, or both. Mao and Wiedman (1999) recently reported similar data that MEF2A is hyperphosphorylated when calcium influx is decreased or when the protein phosphatase calcineurin is inhibited in cerebellar granule neurons. Although other isoforms were not examined in the previous study, the data suggest that enhanced phosphorylation of MEF2A and MEF2D seen on lowering extracellular potassium is likely to be attributable to decreased activity of the calcium-dependent phosphatase calcineurin. Furthermore, because MEF2B and MEF2C did not undergo hyperphosphorylation in response to lowering extracellular potassium, the data indicate that MEF2A and MEF2D are regulated post-translationally in an isotypespecific manner in cerebellar granule neurons.
The putative phosphorylation sites described in this study are functionally distinct from the previously described phosphorylation sites that enhance MEF2 transcriptional activity. Some MEF2 isoforms directly interact with p38 MAP kinase and ERK5/BMK1 and are phosphorylated by both protein kinases (Kato et Other studies in T-cclls have mapped a calcincurin-depcndcnt induction of the nur77 promoter to a putative MEF2 DNA binding site (Youn et al., 1999) . Although the transcriptional activity of MEF2 in activated T-cells requires calcium signals, its DNA binding activity seems to be constitutive and insensitive to changes in calcium. Again, the data arc in contrast to the results of this study in which decreases in intraccllular calcium signaling resulted in decreased DNA binding and transcriptional activity. The antibodies used in T-cclls examining nur77 promoter activity did not distinguish between MEF2 isoforms. This raises the possibility that the discrepancy may be attributable to differential regulation of the various MEF2 isoforms and/or the presence of cell type-specific accessory proteins.
In summary, the complexities in MEF2-rcgulatcd gene expression have been advanced primarily from studies in muscle and T-cells. In the present study we have delineated a novel phosphorylation signaling pathway associated with DNA binding, transcriptional activity, and degradation of neuronal MEF2 proteins. The data in this study also support the hypothesis that MEF2A and MEF2D regulate neuronal survival in the cerebellum, particularly in response to depolarization-induced signals that are important during development. This paper is available on line at http://www.jbc.org \ ptosis induced by various stimuli in Ratl fibroblasts, epithelial cells, and hematopoietic cells (9) (10) (11) . However, the prosurvival effects of Rho GTPases are cell type-and paradigm-specific For example, overexpression of Rac sensitizes NIH-3T3 fibroblasts to serum withdrawal-induced apoptosis (12) . Furthermore constitutively active Rho GTPase mutants enhance susceptibility of CHO cells expressing a chimeric CD4-Fas receptor to Fasmduced apoptosis (13) . Thus, in non-neuronal cells Rho GTPases can display either prosurvival or proapoptotic functions In contrast to non-neuronal cells, comparatively few studies have investigated a role for Rho GTPases in neuronal survival Furthermore, the available data suggest that neuronal cell type-specific responses may exist. For example, dominant-negative mutants of Rac and Cdc42 protect sympathetic neurons from nerve growth factor withdrawal-induced apoptosis bv suppressing activation of apoptosis signal-regulated kinase and ^J un :^-termina i kinase (JNK)i (14, 15) , suggesting that Kno GTPases can function as upstream activators of stressactivated protein kinase cascades during neuronal apoptosis On the other hand, recent data obtained from primary cortical neurons suggest that Rho GTPases may._also mediate prosurvival signaling in some neuronal cell types. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase (statins) decrease the plasma membrane localization of Rho GTPases and induce cortical neuron apoptosis (16) . Similar results utilizing statins to induce apoptosis were also reported recently for rat brain neuroblasts (17) . These latter findings provide indirect evidence that Rho GTPases may play a prosurvival function in some types of neurons.
In the current study, we utilized clostridial toxins enzymes that covalently modify and inactivate Rho family GTPases in a highly specific manner (18) , to investigate if Rho GTPases ^t\ e ^ SUrViVal °f Primary rat «Cellar granule neurons (CGNs). Clostridial toxins provide a distinct advantage over statins m that they directly modify Rho GTPases rather than affecting mevalonate synthesis, a precursor required for the isoprenylation of many cellular proteins besides Rho GTPases CGNs isolated from early postnatal rats provide a well characterized m vitro model to study neuronal apoptosis in that their survival requires serum-derived and activity-dependent (mem brane depolarization) signals (19, 20 (22) , Clostndmm botulinum C2 toxin (23) , and C. botulinum C3 fusion toxm (C2IN-C3) (24) were isolated and prepared as described previously SB203580 (4-(4-fluoro P henyl)-2-(4-methvl-sulfinyl-phenyl)-o-(4-P yridyl).lH-imid-azole), cytochalasin D, anisomycin actmomycin D, and cycloheximide were from Calbiochem. PD169316 Cell Culture-Rat CGNs were isolated from 7-S-day-old Spra-ueDawley rat pups (15-19 g) as described previously (25) . Briefly, neurons were plated at a density of 2.0 X 10° cells/ml in basal modified Ease's medium containing 10% fetal bovine serum, 25 mM KC1 2 m M L glutamme, and penicillin (100 units/ml)-stre P tomycin (100 M g/ml) (Life Technologies, Inc.). Cytosine arabinoside (10 ^M) was added to the culture medium 24 h after plating to limit the growth of non-neuronal cells. Using this protocol, the cultures were -95-99% pure for granule neurons. In general, experiments were P erformed after 7 days in culture. Apoptosis was induced by either removing serum and decreasing the extracellular potassium concentration from 25 mM to 5 m M or by the direct addition of clostridial toxins to complete medium containing serum and 25 mM potassium. Adenoviral Infection-On day 5 in culture, CGNs were infected with either control adenovirus (adenoviral-CMV), adenoviral-CrmA or adenoviral-DN-c-Jun each at an multiplicity of infection of 5-10. After infection cells were returned to the incubator for 48 h at 37 °C and 10% OU 2 . On day 7 the cells were then incubated for an additional 24 h with either vehicle (1 mg/ml BSA in PBS) or 500 pg/ml C. difficile toxin B A P o P tosis was quantified as described above
Preparation of CGN Cell Extracts-After incubation with clostridial toxins for the indicated times s P ecified in the text, the treatment medium was aspirated, CGNs were washed once with 2 ml of ice-cold PBS 9?o t Q-T re thSn plaC6d °n ice and scra P ed int° lysis buffer Y inn -n m J 6 iP containin S 20 mM HEPES (pH 7.4), 1% Triton X-100, oO »M NaCl, 1 mM EGTA, 5 mM ß-glycerophosphate, 30 m M sodium pyrophosphate, 100 " M sodium orthovanadate, 1 m M phenylme hylsulfonyl fluoride, 10 W /ml leupeptin, and 10 M g/ml aprotinin Cell debris was removed by centrifugation at 6,000 x g for 3 min and the protein concentration of the supernatant was determined using a commercially available protein assay kit (Pierce Chemical Co) Aliquot« (-150 Mg) of supernatant protein were diluted to a final concentration of 1 x SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer, boiled for 5 min, and electrophoresed through 10-15% polvacrylamide gels. Proteins were transferred to P olyvinylidene fluoride memanaE.
MmiP0r6 C°rP " ^^ ^ ^ Phospho-c-Jun Immunocytochemistry-CGNs were cultured on polyethyleneimine-coated glass coverslips and were incubated with dosWdlal toxins ± pyridyl imidazole inhibitors as described in the tex After incubation, CGNs were fixed with paraformaldehyde and then perl e abihzed and blocked with PBS (pH 7.4) containing 0 1% Triton X 100 and 5% BSA. Cells were then incubated for -16 h at 4 °C w th S polyclonal anti-phospho-c-Jun (Ser-63) at a dilution fl -? 00 in PBS containing 0.1% Triton X-100 and 2% BSA. The primary aSodywa! aspirated, and the cells were washed five times with PBS Thedll were then incubated with rhodamine-conjugated donkey anti-rabb secondary antibody (1:500) for 1 h at room temperature CGNs were then washed five more times with PBS, and coverslips were adhered to (19 20) . To determine if signals originating from Rho family GTPases are also required for CGN survival, the function of these G proteins was compromised by incubation with clostridial toxins that covalently modify and inhibit specific Rho family members (18) . Toxin B from C. difficile is a monoglucosyltrans ferase that glucosylates a critical threonine residue within the Rho, Rac, and Cdc42 GTPases (26) . Covalent modification of this site interferes with the ability of these G proteins to interact with their downstream effector proteins. Toxin B exhibits a very high degree of substrate specificity in that it glucosylates Rho Rac, and Cdc42, but not other small molecular weight C-rlFases such as Ras, Rab, or Arf (26) Incubation of CGNs for -24 h with very low concentrations of toxm B wO-oOO pg/ml) resulted in significant alterations in nuclear morphology with hallmarks of apoptotic cell death Whereas cells incubated in the presence of vehicle displayed large intact nuclei, toxin B induced significant nuclear condensation and fragmentation (Fig. IA) . Identification of apoptotic F1 nuclei by staining with Hoechst dye revealed a time-and con centrationdependent apoptotic mode of cell death after treat ment with toxin B (Fig. IS) . Primary cultures of rat CGNs were A ,.^G-., 1 Inhl bition of Rho, Rac, and Cdc42 function with C. difficile toxm B induces apoptosis of rat CGNs: cell death is dependent on de novo RNA and protein synthesis. A, CGNs were cultured m medium containing serum and a depolarizing concentration of potassium. On culture day 7, either vehicle (1 mg/ml BSA in PBS left panel) or 500 pg/ml toxin B (right panel) was added directly to'the culture medium, and nuclei were stained 24 h later with DAPI Apoptotic nuclei appear bright, condensed, and sometimes fragmented bcale bar = 20 pm. B, neurons were incubated with varying concentrations of toxin B for 24 or 48 h, and apoptosis was quantitated by nuclear staining with Hoechst dye. Asterisks indicate a significant difference from the control (p < 0.01, n = 3). C, cells were incubated with either vehicle (Veh) or 500 pg/ml toxin B (ToxB) alone or in combination with either 10 M g/ml cycloheximide (CHX) or 2 /ig/ml actinomycin D (ActD) and apoptosis was assessed as described in B. Asterisks indicate asignificant difference from toxin B alone (p < 0.01, n = 3) remarkably sensitive to Rho GTPase inhibition with -80% of the cells undergoing apoptosis after 48 h of incubation with 500 pg/ml toxin B. This latter observation is particularly striking given that cell death occurred in the presence of serum and a depolarizing concentration of potassium. Consistent with previous results that indicate that CGN apoptosis induced by withdrawal of serum and potassium is blocked by inhibitors of RNA or protein synthesis (19) , toxin B-induced apoptosis was similarly prevented by coincubation with either cycloheximide or actinomycin D (Fig. 1C) . Thus, apoptosis of CGNs after inhibition of Rho family GTPases apparently requires the synthesis of proapoptotic proteins.
Requirement for RaclCdc42 GTPases in Neuronal Survival
Apoptotic cell death is orchestrated by the activation of a caspase cascade, proteases that cleave target proteins, including other caspases, at postaspartate residues (for review, see Ref. 27) . Of the caspase family members, caspase-3 is commonly regarded as an "executioner" caspase because its cleavage from an inactive promolecule to an active protease by upstream caspases usually signifies commitment to apoptosis (28, 29) . Caspase-3 activation is a key component of CGN apoptosis induced after the withdrawal of serum and potassium (30) . In a like manner, prolonged inhibition of Rho GTPase function with toxin B led to a significant activation of caspase-3 ( Fig. 2A) . Moreover, adenoviral infection of CGNs with the known caspase inhibitor, CrmA (31), significantly attenuated toxin B-induced apoptosis (Fig. 2B) . Collectively these results indicate that inhibition of Rho family GTPases in CGNs evokes the activation of a caspase cascade that ultimately leads to apoptotic cell death. ' F aaule neurons were incubated for 6 h with either vehicle (PBS containing 1 m g/ml BSA) or 500 pg/ml toxin B (upper panels). Alternatively, cells were incubated for 4 h in either hirff potassium medium containing serum (25K+Serum) or were deprived of serum and potassium (SK-Serum) (lower panels). After treatment, cells were fixed, and nuclear accumulation of phosphorylated c-Jun was analyzed by staining with a phospho-specific antibody that recognizes pi™/ 5 h°ry at f d on Ser -63 ' as ascribed under «Experimental Procedures. Scale bar = 20 y.m. B, cells were incubated for varying times with 500 pg/ml toxin B (ToxB) or for 4 h in low potassium serum-free medium (5K-S). Cell lysates were subjected to SDS-PAGE and immunoblotted(/5) for total c-Jun. C, neurons were incubated for either 6 h with vehicle (Veh) or 500 pg/ml toxin B or for 4 h in 5K-S medium in the absence or presence of either 10 "g/ml cycloheximide (CHX) or 2 ,xg/ml actmomycm D (ActD). Total c-Jun was assessed-by immunoblotting as described under "Experimental Procedures " clei of CGNs (Fig. 3A, lower panels) and an overall increase in total c-Jun (including several distinct phosphorylation variants with differing apparent mobilities) in cell lysates (Fig. W, first  lane versus sixth lane) . Inhibition of Rho, Rac, and Cdc42with toxin B for 6 h also resulted in significant increases in nuclear phospho-c-Jun (Fig. 3A, upper panels) and in total c-Jun detected m cell lysates (Fig. 33) . Furthermore, in accordance with the data presented in Fig. 1C, inhibitors RNA synthesis essentially abolished the increase in c-Jun expression elicited by either toxin B or deprivation of serum and potassium (Fig. 3C) . Thus, apoptosis induced after either an inhibition of Rho family GTPase function or removal of trophic factors is associated with enhanced phosphorylation and expression of the proapoptotic transcription factor c-Jun
Toxin B Elicits an Acute Increase in the Phosphorylation and Expression of c-Jun-Previous
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Requirement for RaclCdc42 GTPases in Neuronal Survival
Akt and GSK3ß Are Regulated Differentially durin* Apoptosis Induced by Toxin B or Withdrawal of Serum and Potassium-Akt is a serine-threonine kinase that has been shown to be downstream of phosphatidylinositol 3-kinase in a prosur-AQ:I yival signaling pathway that is activated.hy both growth factors and mtegrins. The catalytic function of Akt is activated by phosphorylation on Ser-473 by upstream kinases (33 34) UbK3/3 is a putative downstream substrate of activated Akt known to play a proapoptotic role in neurons (25 35) Phosnho rylation of GSK3/3 on Ser-9 by Akt effectively inactivates the kinase activity-ofGSK3/3 and thereby inhibits its proapoptotic function (25 36) . Although withdrawal of serum and potassium from CGNs for 6 h promoted the dephosphorylation (inactivation of Akt (Fig. 4A, last lane) and corresponding dephospho-F4 rylation (activation) of GSK3/3 (Fig. 45, last (Fig. 5, A-C) . Similarly, incubation with C. botulinum C2 toxin, an ADP-ribosyltransferase that directly modifies F-actin (23), resulted in a nearly complete loss of F-actin staining (Fig. 5D) . Interestingly, although incubation of CGNs with each of the above three toxins led to disruption of the actin cytoskeleton, a significant number of condensed nuclei were only observed with toxin B or lethal toxin, but not C2 toxin (Fig. 5) .
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Requirement for Rac/Cdc42 GTPases in Neuronal Survival
In a manner analogous to toxin B, selective inhibition of Rac/Cdc42 with lethal toxin elicited acute increases in both nuclear staining for phospho-c-Jun (Fig. 6A) and total c-Jun detected in cell lysates (Fig. 65) . Lethal toxin also induced caspase-3 cleavage (data not shown), and prolonged incubation of CGNs with either toxin B or lethal toxin resulted in a similar degree of apoptosis (-45% apoptosis after 24 h) (Fig. 6C) . In contrast, specific inhibition of either Rho (with C. botulinum C3 fusion toxin (24)) or Rho kinase (with Y27632 (38)) did not enhance c-Jun phosphorylation or induce CGN apoptosis (data not shown). Furthermore, direct disruption of F-actin with either C2 toxin, cytochalasin D, or latrunculin A was also insufficient to induce either c-Jun phosphorylation/expression (Fig. 6S and data not shown) or apoptosis (Fig. 6C and data not  shown) . These results indicate that a selective inhibition of Rac/Cdc42 function is entirely sufficient to evoke CGN apo-
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ToxB LTox C2Ihi C2I C2IIa +C2I
IB: c-Jun (C2IIa-rC2I) . After treatment, cell lysates were resolved by SDSuJ _ transferred t0 Polyvinylidene fluoride, and membranes were probed for total c-Jun. C, neurons were incubated as described in B for 24 h. Apoptotic cells were quantified by nuclear staining with Hoechst dye. Asterisks indicate a significant difference from the vehicle control (p < 0.01, n = 4). ptosis independently of Rho inactivation. Furthermore, the apoptosis induced after inhibition of Rac/Cdc42 also occurs independently of actin cytoskeletal disruption.
CGNs Possess High Intrinsic JNK Activity and Low Basal p38 MAP Kinase Activity That Are Unaffected by Toxin B-To determine if the increase in c-Jun phosphorylation observed after acute inhibition of Rho family GTPases was caused by an enhancement of stress-activated protein kinase activity, the degree of JNK and p38 MAP kinase activation was assessed in CGNs. CGNs exhibited high basal JNK activity indicated by significant amounts of dually phosphorylated 46-kDa and 54-kDa isoforms of JNK which were only slightly increased by anisomycin exposure (Fig. 1A, first lane versus sixth lane) . Incubation with toxin B for up to 6 h did not significantly increase the high basal JNK activity detected in CGNs (Fig.   F7 eichelbt 7 . Primary cultures of rat CGNs exhibit high basal JNK activity and low basal p38 MAP kinase activity, neither of which is affected by incubation with toxin B. Granule neurons were incubated for varying times with 500 pg/ml toxin B {ToxB) or for 1 h with 10 pit anisomycin (AN). After incubation, cell lysates were subjected to SDS-PAGE, transferred to polyvinylidene fluoride, and probed for either active JNK (p-JNK) (A) or active p38 (p-p38) (B) with antibodies that specifically recognize the Tyr/Thr dually phosphorylated forms of the enzymes. 7A). Relative to JNK activity, the basal p38 MAP kinase activity of CGNs was low as demonstrated by a substantial increase after anisomycin exposure (Fig. IB, first lane versus sixth lane) . Yet, incubation of CGNs with toxin B did not result in a significant increase in the activation of p38 MAP kinase (Fig.  75) . Thus, inhibition of Rho family GTPases does not promote a detectable activation of stress-activated protein kinases in CGNs.
Requirement for RaclCdc42 GTPases in Neuronal Survival
Pyridyl Imidazole Inhibitors ofp38lJNK Signaling andAdenoviral DN-c-Jun Attenuate CGNApoptosis Induced after Inhibition of Rac/Cdc42
Function-Recently, others have reported that CGNs exhibit high basal JNK activity that is largely unaltered by withdrawal of serum and potassium (32) . However, Coffey et al. (39) have demonstrated that a small pool of active JNK may translocate from the cytoplasm to the nucleus in response to stress, where it can then phosphorylate c-Jun. To determine if the high basal JNK activity detected in CGNs was required for the enhanced phosphorylation of c-Jun after inhibition of Rac/Cdc42, we utilized several pyridyl imidazole compounds to inhibit JNK and p38 activities in CGNs. Although this class of compounds has previously been thought to inhibit p38 MAP kinase specifically, a recent report demonstrated that pyridyl imidazoles are also capable of blocking JNK activity in CGNs (40) . Coincubation of CGNs with any one of three different pyridyl imidazole compounds (SB203580 (40) PD169316 (41), or RWJ67657 (42)) significantly attenuated the increase in total c-Jun induced by either toxin B (Fig. 8A ) or lethal toxin (Fig. 8S) . The two more potent compounds, PD169316 and RWJ67657, were also very effective at inhibiting the nuclear accumulation of phosphorylated c-Jun elicited by toxin B (Fig. 8C) . In agreement with c-Jun playing a caus- ative role in CGN apoptosis resulting from inhibition of Ra-, Cdc42, the pyridyl imidazoles significantly blunted apoptosis in cells incubated with either toxin 3 (Fig. 9A) or lethal toxin (Fig.  95) . Moreover, adenoviral DN-c-Jun also significantly attenuated toxin B-induced apoptosis (Fig. 9C) . Thus, an enhanced phosphorylation and expression of the transcription factor, cJun, are required for CGN apoptosis induced by inhibition of Rac/Cdc42 function. 
Requirement for Rac/Cdc42 GTPases in Neuronal Survival
ARTNO: M103959200 vival signaling pathway stimulated by growth factors is a phosphatidylinositol 3-kinase-dependent activation of the antiapoptotic kinase Akt (25, 34, 44) . Thus, CGN survival is promoted by signals originating from both Ca 2+ influx and growth factor receptors.
In the present study, we have identified a novel prosurvival signaling pathway in CGNs which requires the function of Rho family GTPases. Incubation of CGNs with either C. difficile toxin B (an inhibitor of Rho, Rac, and Cdc42) or C. sordellii lethal toxin (a selective inhibitor of Rac and to a lesser extent Cdc42) induced cell death with biochemical and morphological hallmarks of apoptosis. Inhibition of Rac/Cdc42 function promoted activation of caspase-3 and induced nuclear condensation and fragmentation. These effects were not observed in CGNs incubated with specific inhibitors of either Rho (C3 fusion toxin) or the Rho effector, Rho kinase (Y27632). Like apoptosis evoked by withdrawal of serum and potassium (19, 30) , cell death induced by either toxin B or lethal toxin was prevented by inhibitors of RNA or protein synthesis, as well as an inhibitor of caspases (CrmA). Surprisingly, inhibition of Rac/Cdc42 was able to induce apoptosis of CGNs incubated in medium containing both serum and a depolarizing concentration of potassium, suggesting that serum-derived and Ca 2+ -dependeht survival factors cannot compensate for the loss of GTPase function. These observations illustrate that the maintenance of Rac/Cdc42 function is obligatory for CGN survival. Previous work in other neuronal cell systems has yielded somewhat conflicting data on the role of Rho GTPases in neuronal survival. For example, Cdc42 and Rac facilitate apoptosis of primary sympathetic neurons during nerve growth factor withdrawal by activation of an apoptosis signal-regulated kinase/JNK signaling pathway (14, 15) . However, in primary cortical neurons and rat brainneuroblasts the isoprenylation/ plasma membrane localization of Rho GTPases correlates with neuronal survival (16, 17) . Our data are the first to establish clearly a prosurvival function for Rho family GTPases in a neuronal cell model by utilizing highly selective inhibitors of Rho GTPase function (clostridial toxins). Collectively, these data indicate that as in non-neuronal cells, Rho GTPases can play either a prosurvival or proapoptotic role in neuronal cells . depending on the type of neuron studied.
As mentioned above, growth factor-mediated survival of CGNs occurs primarily via a phosphatidylinositol 3-kinase-dependent activation of Akt (25, 34, 44) . Akt, in turn, phosphorylates and inactivates several proapoptotic signaling molecules including GSK3/3 (36) . Many studies have previously demonstrated a relationship between the-Rac GTPase and phosphatidylinositol 3-kinase/Akt activity (45) (46) (47) . Therefore, it was of interest to determine if inhibition of Rac function with C. difficile toxin B affected the activation status of either Akt or GSK3/3 in CGNs. In contrast to serum and potassium withdrawal, which led to an inactivation of Akt and a concurrent activation of GSK3/3, toxin B had no effect on the activation status of either of these kinases. This result demonstrates that Rac does not influence phosphatidylinositol 3-kinase/Akt activity in CGNs significantly.
An inevitable downstream consequence of inhibiting Rho family GTPase function is the disruption of the actin cytoskeleton (26) . In many non-neuronal cells, actin cytoskeletal disruption evokes apoptotic cell death (48) (49) (50) . In the present study, apoptosis of CGNs induced by inhibition of Rho GTPases could be entirely dissociated from actin cytoskeletal disruption because agents that directly disassemble F-actin, C. botulinum C2 toxin, cytochalasin D, and latrunculin A, did not induce cell death within 24 h. Similar results were observed in intestinal epithelial cells that also undergo apoptosis after incubation with toxin B but not cytochalasin D (51) . Our data indicate that the apoptosis observed in CGNs after blockade of Rac/Cdc42 function is likely the result of the inhibition of a specific downstream effector(s) of these GTPases rather than a global perturbation of CGN morphology. In this context, the serine/threonine kinase, p21-activated kinase, is a Rac/Cdc42 effector that has recently been shown to phosphorylate and inactivate proapoptotic signaling molecules such as the Bcl-2 family member Bad (52). Thus, future work will focus on the identification of Rac/Cdc42 effectors that promote survival of CGNs.
Inhibition of Rac/Cdc42 in CGNs induced a marked increase AQ:J ba!t3/bc-bo/bc-bc/bc4201/bc4881-01a 8 eichelbtS=4 11/9/01 18:25 | 4/Color FigurefelT m the phosphorylation, expression, and nuclear accumulation of the transcription factor c-Jun. c-Jun is a required proapoptotic factor in both nerve growth factor withdrawal-induced death of sympathetic neurons (53) and in CGN death after withdrawal of serum and potassium (32) . In primary sympathetic neurons, nerve growth factor withdrawal is associated with an increase in the activity of the stress-activated protein kmase JNK (53) . In contrast, CGNs have been reported to contain high basal JNK activity and low p38 MAP kina*e activity that are unaffected by withdrawal of serum and potassium (32) . The observation that inhibition of Rac/Cdc42 function enhanced c-Jun phosphorylation is somewhat paradoxical m that Cdc42 and Rac have been implicated upstream of JNK activation by several groups (14, 54, 55) . In the present study we observed high basal JNK activity and low p38 activity in control cultures of CGNs, neither of which was significantly increased after incubation with toxin B. Thus, inhibition of Rac/Cdc42 m CGNs increases c-Jun phosphorylation independently of activating stress-activated protein kinase cascades Moreover, these data suggest that JNK activity in CGNs is regulated by a mechanism that is distinct from Rac/Cdc42 signaling. Similar Rac/Cdc42-independent regulation of JNK has been observed in fibroblasts and endothelial cells in response to platelet-derived growth factor and interleukin-1 (56) Finally, pyridyl imidazole compounds that inhibit both p38 and JNK activities in CGNs (40) significantly attenuated both the increase m c-Jun phosphorylation and apoptosis induced after inhibition of Rac/Cdc42 with either toxin B or lethal toxin These results are in agreement with previous data that showed that pyridyl imidazoles also inhibit apoptosis of CGNs evoked by withdrawal of serum and potassium (40) and improve the survival of transplanted neurons in vivo (41) . In addition CGN apoptosis induced by toxin B was also attenuated significantly by adeno V1 ral DN-c-Jun. The above results suggest that the high basal JNK activity detected in CGNs is likely responsible for the enhanced phosphorylation of c-Jun after inhibition of Rac/Cdc42. Furthermore, -c-Jun phosphorylation is required for apoptosis of CGNs in response to Rac/Cdc42 inhibition The mechanism underlying the JNK-mediated phosphorylation of c-Jun m the absence of a detectable increase in JNK activity may involve translocation of a small pool of active JNK to the nucleus (39) . Alternatively, modification of the association between JNK and the JNK-interacting protein JIP, which inhibits the JNK/c-Jun interaction, may also play a role (39) Interestingly, JIP has recently been shown to associate with a guamne nucleotide exchange factor for the Rho family GTPases (57). This latter observation suggests the possibility that active Rho GTPases may be required to maintain the JNK-JIP interaction, and therefore, inhibition of Rho GTPases may release active JNK from JIP, allowing for its interaction with and phosphorylation of c-Jun.
In summary, we have demonstrated that selective inhibition of Rac/Cdc42 with clostridial toxins induces apoptosis of CGNs Cell death was observed in the presence of serum and depolarizing potassium, indicating that growth factor-mediated and Ca ' -dependent survival signals could not compensate for the loss of GTPase function. Apoptosis occurred independently of actin cytoskeletal disruption but required signaling via the transcription factor c-Jun. These data indicate that specific effectors of Rac/Cdc42 GTPases promote the survival of CGN - 
Introduction
Parkinson's disease is a neurodegenerative disorder characterized by progressive deterioration of motor function resulting from the loss of nigrostriatal dopamine neurons and depletion of striatal dopamine [9] . Because L-dopa [6] sought. Despite the success of neural transplants in some Parkinson patients, other patients improve only slightly or not at all. Data from animal [4] and human post-mortem studies [22] indicate that much of the variability in neurotransplantation results from poor survival of transplanted dopamine cells. Although some cells in the transplants probably die by necrosis from handling and shear forces created during implantation, the majority of the observed cell death is apoptotic [27, 46] . The number of apoptotic cells observed in grafts of ventral mesencephalic tissue in parkinsonian rats is greatest during the first 24 h after transplantation and is dramatically reduced by the end of the first week [46] . and execution of apoptosis can be blocked to prevent or reduce neuronal cell death. Recent evidence from a number of laboratories indicates that the stress-activated MAP kinase, p38 MAP kinase, modulates cellular apoptosis. Effects of p38 MAP kinase are complex due to the existence of at least four isoforms, for review see [35] . The activity of p38 MAP kinase is stimulated by factors that induce apoptosis including trophic factor withdrawal [23, 47] , excitotoxic stimuli [20] " and Fas activation [19] . Transfection of cells with constitutively-active upstream regulators of p38 MAP kinase induce apoptosis, whereas, dominant negative upstream kinases block cell death in response to apoptotic stimuli [17, 18, 42, 47] . Peptide growth factors like insulin that support cell survival block the activity of p38 MAP kinase [15] . Finally, pyridinyl imidazole inhibitors of p38 MAP kinase block apoptosis in clonal cell lines [23] and embryonic chick neurons [16] in response to trophic factor withdrawal and in primary cerebellar granule neurons in response to cytotoxic stimuli [20] . In addition to its role in apoptosis, p38 MAP kinase plays a significant role in inflammation [2] , control of the cell cycle, and differentiation of PC 12 cells into neurons [32] .
We have explored the p38 MAP kinase pathway for its role in apoptosis of dopamine neurons and found that inhibitors of p38 MAP kinase improve survival of dopamine neurons both in culture and after neurotransplantation in parkinsonian rats. These inhibitors offer advantages over other anti-apoptotic approaches because they are small organic molecules that are orally active [2, 25] and cross the blood-brain barrier.
Methods
Culture of mesencephalic neurons and detection of apoptosis
E15 rat ventral mesencephalon was dissected as previously described [8] . Primary cultures of rat ventral mesencephalon were prepared in 1 ml of ice cold Ca 2+ / Mg 2+ -free Hanks' balanced salt solution (Mediatech) by mechanically dispersing tissue pieces using a sterile tip of a 1.0 ml Pipetman. Subsequently, cells were centrifuged at 200Xg for 5 min and resuspended in F12 medium (Irvine Sei.) with 5% human placental serum, 2 mM L-glutamine, 100 fig/ml streptomycin, 100 U/ml penicillin, 2.2 u.g/ml ascorbic acid. Cells were seeded at a density of 6.0X10 . Twenty h after media change cultures were fixed in 4% paraformaldehyde. Dopamine neurons were identified using polyclonal anti-rat TH antibody (1:100; Pel-Freez) followed by ABC staining kit (Vector) as described below. Cultures for the studies of apoptosis were fixed in 1% paraformaldehyde followed by 70% ethanol in glycine buffer 18 h after serum withdrawal. These cultures were sequentially incubated with a polyclonal anti-TH antibody (1:100) overnight, anti-rabbit FITC conjugate (1:40; Calbiochem) for 2 h and with 8 |xg/ml of Hoechst 33258 DNA dye for 10 min. TH + cells' (green fluorescence) were counted as apoptotic only if their nuclei (blue) contained one or more lobes of condensed nuclear chromatin. In the entire experiment, a total of 5066 TH + neurons were examined for nuclear chromatin condensation. Four groups were tested: (1) +serum («=2595); (2) -serum (n=269); (3) -serum+10 pM PD169316 (« = 1615); (4) -serum+10 |xM SB203580 («=587).
6-hydroxydopamine lesion and behavioral recovery test
Forty seven male Sprague-Dawley rats (225-250 g) were anesthetized with equithesin (4 ml/kg) and placed In a stereotaxic frame. Unilateral lesions of the medial forebrain bundle were done by infusing 20 |xg of 6-OHDA HBr (RBI), dissolved in 4 JU.1 of sterile saline containing 0.2% ascorbate at 1 uJ/min per site at 2 sites (AP: -2.1 mm posterior to bregma, LAT: 2.0 mm from the midline, VD: -7.8 mm below the dura; and AP: -4.3 mm posterior to bregma, LAT: 1.5 mm from the midline, VD: -7.8 mm below the dura). Animals were tested as previously described [37] for ipsilateral to the lesion turning (90 min) in response to methamphetamine (5.0 mg/kg injected i.p.) two weeks after receiving lesions. Lesioned animals were assigned to four groups of equal rotational rates: (1) vehicle only, («=9, RPM=7.8±1.0); (2) tissue+vehicle (« = 11, RPM=8.4±1.5); (3) tissue+ PD169316 (« = 14, RPM=8.2±0.9); (4) tissue+SB203580 (« = 13, RPM=8.2±0.1). Only rats that rotated at three rpm or greater were included in this study. We have previously demonstrated [37] that in our drug-induced circling test performed in flat-bottomed Plexiglas cylinders circling above two rpm correlates with >95% dopamine depletion. In contrast, Ungerstedt and Arbuthnott demonstrated that, when methamphetamine-induced circling test is performed in hemispherical bowls instead of cylinders, higher circling rates (4-6 rpm) predict >95% dopamine depletion [41] .
Neurotransplantation
E15 rat ventral mesencephalon was dissected according to previously published methods [8] . For transplantation, half of a ventral mesencephalon was shaped into a tissue strand (200 |xm in diameter) by extruding tissue through a tapered glass cannula made by heating a commercially available blank (Kimble Kontes, Cat# 663500-0444). Hemiparkinsonian rats received transplants of ventral mesencephalic strands that were incubated for two h in a 95% air/5%^ C0 2 humidified atmosphere at 37°C in vehicle (Ca 2+ /Mg 2+ -free Hanks' balanced salt solution, n = ll), in vehicle containing 10 p,M PD169316 («=14), or in vehicle containing 10 |xM SB203580 (n = 13). Each animal received a transplant of half of a ventral mesencephalon. Another 9 animals received infusion of only vehicle into the transplant site located in the denervated striatum (AP: 0.0 mm from bregma, LAT: 3.0 mm from the midline, VD: -3.5 to -7.5 mm below the dura) in 4.0 |i,l over 4 min. Animals were tested for response to intreperitoneal methamphetamine (5.0 mg/kg) three and six weeks after receiving transplants. Behavioral recovery was analyzed using mixed-effects analysis of variance appropriate for repeated measures ANOVA.
Morphological evaluation of grafts
All transplant recipients were sacrificed six weeks after transplantation. Graft-containing areas of each brain were sectioned on a cryotome in the coronal plane at 40 \xjm thickness and mounted on glass microscope slides. Every third section was stained for TH-immunoreactivity using a polyclonal antibody against rat TH and ABC staining kit (Vector). Endogenous peroxidase was inactivated by a 20 min treatment in methanol containing 20% hydrogen peroxide (v/v) at room, temperature. Nonspecific binding was blocked with 10% goat serum in PBS containing 1% BSA and 0.3% Triton-X for 60 min at room temperature. The primary anti-TH antibody (1:100 dilution) was applied to each slide overnight at 37°C. Sections were then incubated with a biotinylated goat anti-rabbit IgG antibody and subsequently with avidin/biotinylated horseradish peroxidase complex, each for 2 h at room temperature. The peroxidase was visualized with diaminobenzidine dissolved in PBS and 0.03% hydrogen peroxide.
All TH-positive profiles were counted in each section. Abercrombie's correction [1] assumed cell diameter of 20 H-m and was used to generate the final estimate of the number of surviving dopamine neurons in each animal. To assure that treatment With the inhibitors did not alter dopamine neuron cell size, which would render use of Abercrombie's correction inappropriate, one rat was selected from each transplant group for detailed neuron size analysis. The rat selected had closest to the median value of surviving dopamine neurons for each group. In each selected rat, images of all sections containing grafted cells were captured at X400 magnification into SlideBook digital deconvolution software (Intelligent Imaging Innovations). The size of the soma for all dopamine neurons was determined using SlideBook's analysis tools. The total number of TH + somas measured was 353 for the animal receiving vehicle pre-treated tissue, 439 for the animal receiving PD169316 pre-treated tissue and 500 for the animal receiving SB203580 pre-treated tissue. For the measurement of the graft size and TH + fiber outgrowth, every third section was digitized using a Nikon slide scanner. Using the NIH Image program, area of the graft and area of the fiber outgrowth were manually outlined in each section. The areas were measured by the computer using a calibrated area analysis feature and volumes were calculated from the component areas.
Results
Effects of pyridinyl imidazole compounds on dopamine neuron survival and apoptosis
The survival of embryonic dopaminergic neurons in tissue culture is dependent on the presence of trophic factors contained in serum, and withdrawal of serum results in apoptosis. This model system has been used in the present studies to examine factors that rescue dopaminergic neurons from apoptotic cell death. In each experiment, primary neurons from ventral mesencephalon were grown in the presence of 5% human placental serum for 24 h. At that time, medium was replaced with identical medium or medium lacking serum in the presence or absence of increasing concentrations of the p38 MAP kinase inhibitors PD169316, SB203580, and SB202190. Twenty h after the media change, the cultures were fixed and stained with antibodies against tyrosine hydroxylase (TH) to identify surviving dopamine neurons. The structures of the pyridinyl imidazole compounds used in these experiments are shown in Fig. la . The inhibitors differ only by the para substitution in the phenyl ring that is in the 2-position of the imidazole ring. In control cultures fed with medium containing serum, there were 835±29 surviving TH + neurons/cm 2 (Fig. lb) . Serum withdrawal (20 h) reduced the number of surviving TH + neurons/cm 2 to 122+16 (P<0.001). All of the tested pyridinyl imidazole compounds, when added at the time of serum withdrawal, improved the survival of TH + neurons at concentrations shown to be effective in blocking p38 MAP kinase activity [7] . The survival effects of SB203580 and SB202190 reached their maximum at 100 and 200 pM, respectively. crystals, which might have contributed to increased variability in cell survival observed in these cultures. Cultures supplemented with 10 |xM of SB203580 or SB202190, at which concentration crystal formation was not a problem, had 470±56 and 601 ±48 surviving TH + neurons/cm 2 ! respectively. By contrast, 10 ixM PD169316 protected all of the TH + neurons from serum withdrawal-induced death, supporting the survival of 1008±126 TH + neurons/cm 2 . These experiments have revealed that all three inhibitors can fully protect dopamine cells from serum withdrawal. The order of potency for complete neuroprotection from serum withdrawal was PD169316>SB203580>SB202190. In some cases, high concentrations of the inhibitors augmented TH + cell survival above that observed in serum-containing cultures (PD169316 at 55 and 100 uJVI, SB203580 at 100 uJVf, and SB202190 at 200 uJVI, P< 0.01).
The morphology of TH + neurons grown in the absence and presence of serum is shown in Fig. 2 . Twenty h after the media change, dopamine neurons cultured in medium containing serum (with or without 10 \iM PD 169316) appeared healthy and contained long neurites and highly ramified growth cones (Fig. 2a, c) . By contrast, dopamine neurons from which serum was withdrawn were fewer in number, had truncated neurites and lacked growth cones (Fig. 2b) . Supplementation of the serum-withdrawn cultures with 10 IJLM PD169316 rescued the TH + neurons. Their morphology was indistinguishable from that of the serum-fed neurons (Fig. 2d) .
To determine if PD 169316 exerted its survival effects on dopamine neurons by reducing the rate of apoptosis, we co-stained rat ventral mesencephalic cultures with TH antibodies to identify surviving dopamine neurons and Hoechst 33258 dye to examine nuclear morphology. Apoptotic dopamine neurons were defined as TH + cells that contained one or more lobes of condensed nuclear chromatin. In the presence of serum, greater than 90% of TH neurons showed normal nuclear morphology with the chromatin uniformly distributed throughout the nucleus (Fig. 3a) . The apoptotic dopamine neurons showed marked nuclear condensation and had degenerating neurites (Fig.  3b) . Maintenance of cell membrane integrity in the apoptotic dopamine neurons, another characteristic of apoptosis, was demonstrated by retention of TH enzyme within the apoptotic bodies (Fig. 3b) . Removal of serum increased the number of adherent apoptotic cells by over 3-fold (Fig. Fig. 2 . PD169316 protects dopamine neurons from degeneration in vitro, (a-d) Micrographs of dopamine neurons 20 h following media change Cells were -ostamed using antt-TH antibody, (a) 5% serum on.y; (b) no serum; (c) 5% serum plus 10 o.M PD1693.6; (d) no seru m pluf 0 aM PD 69316 n these expenments, PD169316 acted as serum rep.acement. 10 oM PD169316 (d) restored both dopamine neuron survival and "e rite1^ t t observed ,n serum-contammg cultures (a). Note that addition of PD169316 to cu.tures supplemented with serum (c) did not further increa dopli e e survival or neunte outgrowth. Scale bar= 100 fun.
""CöC uopamme ceil 3c). PD169316 reduced the rate of apoptosis of dopamine neurons to control levels and SB203580 partially reduced the level of apoptosis seen after serum withdrawal.
Effects of pyridinyl imidazole compounds on dopamine neuron survival and function after transplantation
To determine whether inhibitors of p38 MAP kinase could increase the survival of dopamine neurons and accelerate motor recovery after transplantation, we transplanted rat ventral mesencephalic dopamine neurons obtained from embryonic day 15 rats into the brains of hemiparkinsonian rats. This rat model of Parkinson's disease is created by a unilateral injection of the neurotoxin 6-OHDA into the medial forebrain bundle leading to the death of dopamine neurons in substantia nigra and dopamine depletion in striatum [37, 41] . Upon intraperitoneal injection of methamphetamine (5 mg/kg), lesioned animals run in circles in a direction ipsilateral to the lesion. This circling behavior can be abolished by transplantation of embryonic rat dopamine neurons into the denervated striatum [5] . Grafted dopamine neurons survive, project neuntes, form synapses, and improve behavior [26] .
Rats were lesioned and tested for rotational behavior two weeks later. Lesioned rats that showed motor asymmetry (greater than 3 rpm) in response to methamphetamine were transplanted with one of the following: (1) vehicle only; (2) mesencephalic tissue pretreated "with vehicle; (3) mesencephalic tissue pretreated with 10 pJVI PD169316 or (4) mesencephalic tissue pretreated with 10 uM SB203580. For the pretreatment, all tissues were incubated for two h in a 95% air/5% C0 2 humidified atmosphere at 37°C. Inhibitor concentration of 10 pM was chosen for the transplantation experiments, because higher concentrations of the inhibitors result in an unacceptably high crystal formation upon contact with aqueous solutions. Inhibitors of p38 MAP kinase that have much better solubility in aqueous solutions are being developed [25] .
Behavioral recovery was tested at three and six weeks following transplantation. Animals that received vehicle without tissue did not reduce their rotational rate over the six-week period. At three weeks, animals that received transplants of tissue pretreated with vehicle alone reduced their circling rate by 60% from the pretransplantation rate (Fig. 4) . By contrast, recipients of transplants pretreated with the pyridinyl imidazole compounds had significantly accelerated reduction in their rotational rates when compared to the vehicle pretreated tissue recipients. The PD 169316 pretreated group reduced their rotational rate by 90% (P<0.01), while the SB203580 pretreated group reduced their circling by 74% (P<0.01). At six weeks after transplantation, behavioral improvement continued (Fig. 4) . The vehicle pretreated group showed a 77% 190 W. Michael Zawada, et at. I Brain Research 891 (2001) [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] + serum serum -serum -serum + 10\M +10uM PD169316 SB203580 reduction in circling. The PD169316 pretreated group showed the greatest reduction in circling (99%) and was significantly different from the control group (P<0.01). The SB203580 pretreated group reduced their rotational rate by 82%, a value not statistically different from the vehicle pretreated group. Thus, animals receiving mesencephalic tissue that was pretreated with PD 169316 completely stopped circling at six weeks after transplantation.
To determine if behavioral improvement coincided with increased survival of dopamine neurons in the grafts, animals were sacrificed and their brains processed for tyrosine hydroxylase immunocytochemistry. Examples of coronal sections through grafts stained for TH are shown in Fig. 5a . Cell counting of TH + neurons in these coronal sections revealed that 1550±294 dopamine neurons survived in grafts pretreated with vehicle (Fig. 5b) . The number of surviving TH + neurons doubled to 3023±518 when the tissue was pretreated with PD169316 (P<0.05). Although pretreatment of tissue with SB203580 increased the number of surviving dopamine neurons to 2321 ±394, the increase was not statistically significant. Analysis of the graft size (Fig. 5c ) and TH + fiber outgrowth (Fig. 5d ) using the NIH Image program revealed that pretreatment of mesencephalic tissue with PD169316 prior to transplantation increased the graft size by 140% (P<0.01), while pretreatment of the tissue with SB203580 increased the graft size by 100% (P<0.05). Preincubation with either PD169316 or SB203580 also augmented the TH + fiber outgrowth by 130% (P<0.01).
To assure that treatment with the inhibitors did not alter dopamine neuron cell size, which would render use of Abercrombie's correction inappropriate, one rat was selected from each transplant group for detailed neuron size analysis. The rat selected had closest to the median value of surviving dopamine neurons for each group. Measurement of soma size of TH + neurons from images captured at X400 magnification into SlideBook digital deconvolution software revealed that average area of TH + cell soma was not changed by the ex vivo inhibitor treatment (Fig.  6) . Specifically, average area of TH + cell soma of cells in tissue treated with the vehicle was 177±4 txm 2 , 180±3 uV in tissue treated with PD169316,_and 172 ±3 u.m 2 in tissue treated with SB203580.
Discussion
Results from these studies indicate that pyridinyl imidazole inhibitors of p38 MAP kinase improve survival of dopamine neurons both in tissue culture and after neurotransplantation in hemiparkinsonian rats. The improved survival of grafts treated with the p38 MAP kinase inhibitors correlated with more rapid improvement in motor behavior. These data suggest that apoptotic pro- (4) tissue+10 u.M SB203580 (« = 13). Rats were tested prior to transplantation (two weeks after lesioning) and three and six weeks after transplantation. At three weeks, groups transplanted with tissues treated with both PD and SB compounds had significantly lower rotational scores than controls receiving vehiclepretreated tissue (/><0.01). PD169316 treated group was the only group to stop rotating at six weeks after transplantation (P<0.01 vs. tissue+ vehicle). Data are mean±S.E.M. Significance was determined usin^ two-way ANOVA (P<0.001; F { , Kr "=4.7)-followed by a Fisher LSD post-hoc test.
grammed cell death occurring in vivo after transplantation results, at least in part, from activation of p38 MAP kinase. This outcome is consistent with in vitro experiments showing that inhibitors of p38 MAP kinase block apoptosis of neurons [15, 16, 23] . In differentiated PC12 cells that were deprived of nerve growth factor (NGF) for 16 h, activity of p38 MAP kinase was dramatically elevated and correlated with increase in apoptosis [23] . A selective p38 MAP kinase inhibitor, PD 169316, and insulin abolished this increase in kinase activity and blocked apoptosis in PC 12 cells under conditions of NGF withdrawal. 14J. statistical analysis Pyridinyl inhibitors of p38 MAP kinase, SB203580 and SB202190, have been also shown to protect different populations of chick embryonic neurons from apoptosis induced by trophic factor withdrawal in vitro [16] . Although SB203580 and SB202190 partly protected sensory, sympathetic, ciliary and motor neurons from trophic factor withdrawal, using an optimal concentration of the inhibitors (100 |xM), ciliary neuron survival was increased to no more than 80% of controls. Effects on the other types of embryonic chick neurons were lesser. By contrast, in our study, concentrations of PD 169316 as low as 10 u,M protected 100% of dopamine neurons from serum withdrawal-induced apoptosis. Our experiments also revealed that all p38 MAP kinase inhibitors, when tested at 100 jxM in mesencephalic cultures from which serum was withdrawn, significantly increased dopamine neuron survival above that observed in serum-fed cultures. Activation of p38 MAP kinase by trophic factor withdrawal is not unique to neurons, as Rat-1 fibroblasts deprived of serum exhibit similar increases in apoptosis and p38 MAP kinase activity, both of which can be blocked by PD 169316 [23] .
While in our mesencephalic cultures morphology of the dopamine neurons protected by PD 169316 was identical to that observed in serum-fed cultures, in chick embryonic neurons, under trophic factor withdrawal, the SB compounds were unable to fully restore normal neunte mor- °f ™ -yt^-SÄ phology [16] . Because one of the initial morphological changes characteristic of apoptosis is neurite degeneration, it is possible that inhibitors of p38 MAP kinase maintain normal neuronal morphology in cultures deprived of trophic factors by inhibiting the pro-apoptotic cascades in the neuntes and synaptic terminals. Evidence of synaptic apoptosis is growing, for reviews see [29, 30] . Exposure of isolated synaptosomes to staurosporine and Fe 2+ , at concentrations that induce apoptosis in cultured primary neurons, produced changes characteristic of apoptosis including flipping of phosphatidylserines to the outer leaflet of the membrane, activation of caspase-3, mitochondrial calcium uptake, mitochondrial membrane depolarization and accumulation of oxygen radicals [31] . Caspase activation and mitochondrial membrane depolarization precede and are required for nuclear apoptotic events. In glutamate-induced apoptosis, signals for caspase activation are propagated from dendrites toward the soma [31] .
The other member of stress-activated protein kinase family, c-Jun N-terminal kinase (JNK), is activated by many of the same apoptotic stimuli that activate p38 MAP kinase. In three models of survival factor withdrawalinduced apoptosis, JNK was determined to be necessary using dominant negative mutants of JNK, its downstream target c-jun, and its upstream activator [13, 14, 47] . Recent evidence using novel inhibitor of the JNK signaling pathway, CEP-1347, points to JNK1 as a mediator of trophic factor withdrawal-induced apoptosis in motoneurons [28] . Potential importance of the stress-activated protein kinase pathways in apoptosis is further underscored by findings showing rapid activation of both JNK and p38 MAP kinase in primary cerebellar granule neurons following exposure to glutamate [20] , The p38 MAP kinase activation in cerebellar granule neurons occurred via Nmethyl-D-aspartate receptors and involved calcium. Similarly to the antiapoptotic effects of SB203580 on the PC 12 cells and fibroblasts exposed to serum withdrawal, inhibition of p38 MAP kinase using SB203580 reduced glutamate-induced apoptosis in cerebellar granule cells [20] .
It is conceivable that inhibition of apoptosis by SB203580 and PD169316 observed in our study resulted from a combined blockade of activities of both p38 MAP kinase and JNK. This conjecture is supported by a recent report showing that SB203580 can inhibit JNK activity in CHO cells [44] . While 0.1 |xM SB203580 inhibited more than 50% of p38 MAP kinase activity with no effect on JNK1 and 2 activity, incubation of the cells with 10 (xM inhibitor reduced the activities of JNK2ßl and JNK2ß2 to basal levels [44] .
To our knowledge, our report is first to describe neuroprotective actions of p38 inhibitors in vivo. Despite the rescue of many of the transplanted dopamine neurons by p38 MAP kinase inhibitors, the majority of dopamine neurons did not survive transplantation. Further improvement in grafting may come from short-term systemic administration of the inhibitors to sustain higher inhibitor concentration during the first week after grafting when neuronal apoptosis is greatest [46] . This short treatment paradigm may reduce potential for toxicity of long-term treatment, thereby enhancing the potential for use of these inhibitors in humans. More potent and more soluble p38 MAP kinase inhibitors are being developed [25] .
Several other approaches to improve survival and function of dopamine neurons in transplants have shown some promise, for review see [4] . Preincubation of ventral mesencephalic tissue prior to transplantation with a combination of basic fibroblast growth factor (bFGF), insulinlike growth factor-I (IGF-I), and glial-cell line derived neurotrophic factor (GDNF) results in improved survival of transplanted dopamine neurons one and seven days following transplantation [46] . These survival-promoting effects of the growth factors are attributed to the reduction in the number of apoptotic cells following grafting. Alternatively, co-transplantation of naturally occurring or genetically-modified cells together with ventral mesencephalic cells has been shown to enhance graft survival and function. Testis-derived Sertoli cells, known for their ability to produce a variety of growth factors and Fas ligand, when co-transplanted with the rat ventral mesencephalic cells enhance survival of dopamine neurons in the grafts [45] . Co-transplantation of rat fibroblasts genetically modified to express bFGF also improved graft survival and function [40] .
In yet another strategy, transgenic neural tissue was used in attempts to reduce oxidative stress and apoptosis following transplantation. Grafting of transgenic mouse ventral mesencephalon overexpressing Cu/Zn Superoxide dismutase enhanced survival of transplanted dopamine neurons in a rat model of Parkinson's disease [34] , Comparable improvements in dopamine neuron survival have been observed in grafts receiving cells treated with inhibitors of free radical generation, lazaroids U-743889G and U-83836E [33] . By contrast, efforts to inhibit apoptosis in transplanted neurons by grafting mouse mesencephalic tissue overexpressing an anti-apoptotic protein, Bcl-2, failed to improve survival and function of the grafts, but resulted in a significant enhancement of dopaminergic fiber outgrowth [39] . A more efficatious method for reducing apoptosis in the grafts employed a pretreatment of the mesencephalic cell suspensions with a caspase inhibitor, Ac-YVAD-cmk, prior to transplantation [38] . Grafts receiving cells exposed to the caspase inhibitor contained nearly 400% more surviving dopamine neurons than control grafts.
Further potential for augmenting graft survival and overall transplant outcome may lie in the use of the p38 MAP kinase inhibitors in combination with growth factors [40, 46] , antioxidants [33, 34] , or other antiapoptotic agents such as caspase inhibitors [38] , which when used as monotherapy have already been shown to be beneficial. The advantages that the pyridinyl compounds have over growth factors and caspase inhibitors for preventing apoptosis in vivo include their low molecular weight, acceptable systemic toxicity [2, 25] and ability to cross the blood-brain barrier. These characteristics make the pyridinyl imidazole compounds promising candidate drugs for improving survival of dopamine-neurons following transplantation into humans.
INTRODUCTION
In Parkinson's disease, progressive deterioration of motor function results from the loss of nigrostriatal dopamine neurons and consequent dopamine depletion in the caudate and putamen (17) . Among neurological disorders, Parkinson's disease is a prime candidate for a new strategy for treatment because drug therapy loses its effectiveness after 5 to 10 years. In 1979, Björklund and Stenevi (5) and Perlow et al. (43) demonstrated the potential benefits of mesencephalic grafts in parkinsonian rats. Since then, fetal tissue transplantation has been developed as a treatment for Parkinson's disease in humans (19-26, 32, 35, 59 ). Decisions about the appropriate age of human fetal donor tissue and its preparation have been based on extrapolation from the embryonic development of rodents as well as direct transplantation of human fetal tissue into parkinsonian rats (11, 26, 31, (49) (50) (51) (52) (55) (56) (57) (58) .
A major problem with neurotransplantation is that up to 95% of embryonic dopamine neurons die after transplantation (7, 33) . Since cells in transplants of embryonic mesencephalon have been shown to undergo apoptotic cell death in vivo (36, 62), we and others are examining possible uses of neurotrophic factors to reduce apoptosis (12, 13, 28, 37, 38, 47, 48, 61, 62) . Two of the growth factors being examined are insulin-like growth factor-I (IGF-I) and basic fibroblast growth factor (bFGF) which improve dopamine neuron survival in vitro (30) and in vivo (53) . We have recently shown that dopamine neuron survival can be improved by a 2-h preincubation of transplanted tissue with the growth factor combination of glial cell line-derived neurotrophic factor (GDNF), IGF-I and bFGF (62). We have also shown that a combination of IGF-I and bFGF reduces the rate at which dopamine neurons undergo apoptosis in vitro (61). The growth factors may be acting indirectly through stimulation of trophic factor production by astrocytes (18) , since the neuroprotective effect can be blocked by inhibition of astrocyte proliferation with cytosine arabinoside (61). We have found that most dopamine cell death occurs in the first day to the first week after transplant (62). This result indicates that short-term induction of astrocytes by IGF-I and bFGF in vivo may be sufficient to protect transplanted dopamine neurons from programmed cell death.
To provide time for quality control of tissue prior to transplantation, we have developed methods for maintaining human embryonic cells in culture for extended periods of 1 to 4 weeks prior to transplant (20, 21) . In a further effort to improve survival of cells after transplant, we have now tested whether long-term (14 in vitro incubation of human fetal tissue with the combination of IGF-I and bFGF will promote the subsequent survival of these cells after transplantation into hemiparkinsonian rats.
Currently in our laboratory, strands of human fetal tissue placed in tissue culture are tested for dopamine production by measuring the concentration of the dopamine metabolite homovanillic acid (HVA) in tissue culture supernatant. The in vitro storage method is also critical for accumulating a sufficient quantity of tissue for transplantation and for demonstrating that the tissue is not infected with bacteria, viruses, or fungi. The in vitro environment provides an opportunity to treat tissue with trophic factors in an effort to improve survival of cells following transplantation.
MATERIALS AND METHODS
Preparation of Fetal Tissue
Postmitotic embryonic dopamine cells from early in development, 13 to 15 days after conception in the rat and 45 to 55 days after conception in the human (40) , are able to survive and develop when implanted in the adult Parkinsonian brain (9, 10, 33, 50) . Only tissue from human embryos in this developmental range was used in this study.
Fetal tissue was obtained after elective abortion by standard clinical methods and with the use of sterile collection apparatus. Women donating tissue signed specific informed consent for experimental use of tissue. The consent and all collection methods complied with state and federal laws and were approved by the Colorado Combined Institutional Review Board. The rostral half of ventral mesencephalon containing dopamine cells was dissected as a block about 2 by 4 by 1 mm. This block was then cut in half down the midline to generate two identical pieces of mesencephalon. These pieces are referred to subsequently as a "matched pair." The tissue was washed in three petri dishes each containing -20 ml of cold calcium-and magnesium-free Hanks' balanced salt solution (HBSS).
Tissues strands were created by extruding one half of a mesencephalon through a glass cannula with a luer adaptor at one end and a taper to a 0.2-mm bore at the other (14, 20, 21) . These extruders were made by heating and drawing a commercially available blank (Kimble Kontes, Cat. No. 663500-0444, Vineland, NJ). Mesencephalic tissue was aspirated into the hub of a 1 ml tuberculin syringe in HBSS and then slowly ejected through the buffer-filled glass extruder. Care was taken to avoid excess pressure during extrusion, which could cause compression/decompression damage to the tissue. Strands were extruded into 4 ml culture medium in one well of a six-well plastic tissue culture plate (Corning Inc., Corning, NY). Medium was F12 containing 5% dialyzed human placental serum (heat inactivated at 55°C for 30 min), heparin (1 /xg ml" 1 Human recombinant IGF-I (150 ng/ml; Cephalon Inc., Philadelphia, PA) and human recombinant bFGF (15 ng/ml; Scios Inc., Mountain View, CA) were added to the medium immediately after strands were placed in culture. Medium was changed at 3, 6, 9, 12, and 14 days after strands were placed in culture. This was done by removing and freezing 2 ml of medium for later HVA analysis and then adding 2 ml of fresh medium together with fresh IGF-I and bFGF.
High-Performance Liquid Chromatography (HPLC) Analysis
Testing for the content of HVA in tissue culture extracts used HPLC with electrochemical detection (Bioanalytical Systems) as previously described (3, 29) . Separation was achieved on a Spherisorb ODSA microbore column (1 X 100 mm, Keystone Scientific) using a mobile phase containing, per liter, 13.7 ml phosphoric acid, 4.1 g trichloroacetic acid, 0.5 g sodium EDTA, 0.4 g octyl sodium sulfate, and 8% methanol (pH 3.0). Any detectable HVA in the medium blank was subtracted from each sample.
Unilateral 6-OHDA Injections
Male Sprague-Dawley rats (250-350 g) were anesthetized with equithesin (4 ml/kg) and placed in a stereotaxic frame. A 30-gauge cannula was then lowered into the medial forebrain bundle at the following coordinates: AP, -4.3 mm posterior to bregma; L, 1.5 mm from the midline; VD, -7.5 mm from the dura (42) . Ten micrograms of 6-OHDA HBr (RBI, Natick, MA), dissolved in 5 /xl sterile saline containing 0.2% ascorbate, was infused at 1 ^,1/min over 5 min (55) . The cannula was left in place an additional 2 min with no infusion. Then the pump was started and the cannula was withdrawn while infusing saline. Lesions were tested behaviorally as noted below and confirmed histologically postmortem by the unilateral loss of THimmunoreactive dopamine neurons in the substantia nigra.
Methamphetamine and Apomorphine-Induced Rotation
Two weeks after surgery, the completeness of the lesion was assessed by measuring turning behavior in response to methamphetamine HC1 (5.0 mg/kg, ip, Sigma) and apomorphine (0.05 mg/kg, sc, Sigma) in a flat-bottomed rotometer. Methamphetamine circling was selected as the primary behavioral variable. Briefly, the rotometer consisted of a plexiglass cylinder 185 20 cm in diameter. The rat was tethered to a counter with a harness fastened around its chest. Rats that circled ipsilateral to the lesion more than 3.0 rpm during the period of 30 to 120 min after methamphetamine injection were used for transplantation and further rotational testing. Average ipsilateral rotation of animals chosen for the experiments was 8.3 rpm for controls and 7.2 rpm for IGF-LfoFGF-treated group. We have previously demonstrated (45) that in our meth-.y amphetamine-induced circling test performed in flat-^ bottomed Plexiglas cylinders, circling above 2 rpm cor-* relates with >95% dopamine depletion. In contrast, * Ungerstedt and Arbuthnott demonstrated that when methamphetamine-induced circling test is performed in hemispherical bowls instead of cylinders, higher circling rates (4-6 rpm) predict >95% dopamine depletion (55). Circling after apomorphine was also addressed. Rats that showed apomorphine-induced turning contralateral to the lesion of greater than 3.0 rpm during the period of 0 to 30 min after injection were considered to be positive for an apomorphine effect and had apomorphine data collected. Average apomorphine-induced rotation of animals chosen for the experiments was 8.1 rpm for controls and 6.1 rpm for IGF-I/bFGF-treated group. Of the six pairs of rats that were positive for methamphetamine-induced rotation, only five pairs were positive for apomorphine-induced rotation. Methamphetamine-and apomorphine-induced turning was measured 4, 8, and 10.5 weeks after transplantation to test the behavioral effect of developing neural grafts. To prevent possible confounding of drug test effects, methamphetamine-induced turning was measured 48 h after apomorphine testing.
Transplantation of Embryonic Tissue
Recipient animals were anesthetized with equithesin (4 ml/kg). Three burr holes were made through the skull and a 20-gauge guide cannula supported by a motorized stereotaxic arm (Narishige, Tokyo) was used for transplantation. The cannula was lowered into the brain to 3.0 or 3.5 mm below the dura. Three transplant sites were required to accommodate all of the tissue present in one-half of a human mesencephalon. Transplant coordinates were: (i) AP 0.0 mm from bregma, L 2.0 mm from midline, VD -7.0 to -3.0 mm below dura; (ii) AP 0.0 mm from bregma, L 3.5 mm from midline, VD -7.5 to -3.5 mm below dura; and (iii) AP 1.0 mm anterior to bregma, L 3.5 mm from midline, VD -7.0 to -3.0 mm below dura. Animals were paired based on whether they received growthfactor-treated or nontreated tissue from the same human mesencephalon.
Matched pair tissue strands representing half-mesencephalons were removed from tissue culture, reextruded as described above, and then drawn up into a 24-gauge Stainless-steel transplantation cannula in a volume between 4 and 8 jui. The transplantation cannula (which protruded 4 mm beyond the guide) was then inserted through the guide cannula to a final depth of 7 or 7.5 mm below the dura. The tissue was ejected with the aid of a syringe pump over 4 min. For each transplant, the pump was switched on and allowed to run for 15 s and then the cannula was withdrawn at a rate of 1 mm/min with the pump running. At the top of the tract (after 4 min) the pump and guide cannula were stopped for 2 min to allow the pressure to equilibrate. Afterward, withdrawal was continued while about 4 /il of HBSS was pumped through the cannula. No sham transplants were done since in our previous work we found that shams had no improvement in amphetamine-(44) and methamphetamineinduced rotation (15, 60) . All transplanted rats were immunosuppressed 24 h prior to transplantation with cyclosporine A (Sandimmune; 10 mg/kg; sc; Sandoz) and daily thereafter for the duration of the experiment.
Tyrosine Hydroxylase Immunohistochemistry
At 10.5 weeks after transplant, following behavioral testing, animals were killed by chloral hydrate overdose (2 g/kg, ip) and intracardially perfused with heparinized saline (30 units/ml) followed by 4% phosphatebuffered paraformaldehyde. The brains were postfixed for 2 days in the same fixative and cryoprotected in 30% sucrose. Forty-micrometer sections were cut on a freezing microtome, and each section was processed for TH immunohistochemistry.
The staining procedure supplied by the manufacturer was used. After blocking for 1 h with 10% goat serum, 1% BSA, and 0.3% Triton-X at 37°C, the slices were incubated in polyclonal, affinity-purified rabbit anti-rat TH antibody 1:200 (Pel-Freez, Rogers, AR) for 16 h at 37°C. Sections were then incubated with a secondary biotinylated, affinity-purified, goat anti-rabbit IgG antibody and subsequently with avidin/biotinylated horseradish peroxidase complex, each for 4 h at room temperature (Vector Lab, Burlingame, CA). The peroxidase was visualized with diaminobenzidine dissolved in PBS and 0.03% hydrogen peroxide.
Anatomical Analysis
The total number of dopamine neurons within the transplant tracts was estimated by counting all THpositive cells in every third section from the area of the striatum-containing transplant. Sequential section stereological counting (16) was not possible since the 40-/xm sections were collected six sections per single well of a 24-well plate and were thus randomized per well. For each animal, sections were collected in multiple wells and at least 16 sections from each transplant were examined for the presence of dopamine neurons. Abercrombie's correction (1) with an assumed cell diameter of 20 /xm was used to generate the final estimate of the number of surviving dopamine neurons in each animal. Work previously done in our laboratory has shown that treatment with a combination of IGF-I and bFGF does not affect transplanted dopamine neuron size (14) . To assure that treatment with IGF-I and bFGF did not alter dopamine neuron cell size, which would render use of Abercrombie's correction inappropriate, one rat was selected from each transplant group for detailed neuron size analysis. The rat selected had closest to the median value of surviving dopamine neurons for each group. In each selected rat, images of all sections containing grafted cells were captured at X400 magnification into SlideBook digital deconvolution software (Intelligent Imaging Innovations). The size of the soma for all dopamine neurons was determined using SlideBook's analysis tools. The total number of TH + somas measured was 197 for the control and 408 for the animal receiving IGF-I/bFGF treatment.
Statistical Analysis
The behavioral data were analyzed via SAS Procedures GLM and Mixed (SAS Institute, Cary, NC) using a mixed effects model appropriate for repeated measures data (34) . This method accounts for variability between rats as well as between multiple measurements on the same rat. The TH + neuron survival and TH + neuron soma size data were analyzed using Student's t test and InStat statistical software (GraphPad, San Diego, CA).
RESULTS
Measurement of the stable dopamine metabolite HVA in the medium of cultured fetal strands provides evidence for ongoing production of dopamine in the tissue culture (Fig. 1) . Levels of HVA production per day appeared to be lower in fetal strands treated with the combination of IGF-I and bFGF, though these differences did not reach statistical significance (n = 6, P > 0.2). The same trend was seen in cumulative HVA levels, with IGF-I/bFGF-treated strands producing a total of 320 ± 130 pmol after 14 days in vitro and untreated control strands producing 490 ± 130 pmol after 14 days in vitro (data not shown). This difference was not statistically significant. Figure 2 shows that animals receiving growth-factor-treated human fetal mesencephalon had a significantly greater behavioral improvement than animals transplanted with human mesencephalon not treated with growth factors. Transplants of growth-factortreated strands led to a significant reduction in methamphetamine-induced rotation at 10.5 weeks posttransplant when compared to control strands (P < 0.05; Fig. 2A ). Growth-factor-treated strands appeared to cause a more rapid improvement in apomor- Testing for the content of HVA in tissue culture extracts was done by HPLC with electrochemical detection (2, 32) . All data represent the mean ± SEM (n = 6 pairs).
phine circling when compared to control strands (Fig.  2B) . However, these apparent differences did not reach statistical significance (P > 0.05). By 10.5 weeks, both groups had nearly stopped circling to apomorphine, indicating that enough human dopamine cells survived to eliminate apomorphine circling.
The number of surviving dopamine neurons in grafts of animals sacrificed 10.5 weeks after transplant is shown in Fig. 3A . Transplants of fetal tissue strands treated with the combination of IGF-I/bFGF had better dopamine neuron survival than untreated control grafts. In animals receiving one-half a human mesencephalon treated with growth factors, a total of 2380 ± 440 dopamine neurons survived (Fig. 3A) . By contrast, animals receiving the non-growth-factor-treated half mesencephalon had only 1240 ± 250 surviving dopamine neurons (P < 0.05; Fig. 3A) . Photomicrographs of representative sections from untreated and growthfactor-treated grafts are shown in Figs. 3B and 3C.
To assure that growth factor treatment did not alter dopamine neuron cell size, which would render use of Abercrombie's correction inappropriate, one rat was selected from each transplant group for detailed neuron size analysis. The rat selected had closest to the median value of surviving dopamine neurons for each group. Measurement of soma size of TH + neurons from images captured at X400 magnification into SlideBook digital deconvolution software revealed that average area of TH + cell soma was not changed by the ex vivo growth factor treatment (Fig. 4A) 
DISCUSSION
Our study demonstrates that treating individual fragments of human fetal ventral mesencephalon with a combination of IGF-I/bFGF for 2 weeks in tissue culture leads to better survival of dopamine neurons after transplant into immunosuppressed hemiparkinsonian rats. Previous work in our laboratory has shown that combinations of IGF-I and bFGF reduce the rate of apoptotic death in rat dopamine neurons in vitro (61), and pretreatment with a combination of GDNF, IGF-I, and bFGF improves cell survival after transplant (62). Cotransplantation of bFGF-expressing fibroblasts with rat mesencephalic dopamine neurons greatly enhanced survival of transplanted cells and accelerated behavioral recovery (53) . We hypothesize that treatment of human fetal tissue with IGF-I/bFGF reduces the rate of apoptotic death that occurs while the strands are in Tissue was transplanted into striatum of 6-OHDA-lesioned rats. (A) rotational rate induced by methamphetamine (5 mg/kg, ip). Animals receiving growth-factor-treated strands had an improvement at 10.5 weeks posttransplant compared to controls. Asterisk represents statistical significance at P < 0.05 compared to controls using a mixed effects analyses of variance (29) (n = 6 pairs) and (B) rotational rate induced by apomorphine (0.05 mg/kg, sc). Animals receiving growthfactor-treated strands had their rotational rate induced by apomorphine measured at 4, 8, and 10.5 weeks after transplantation. Although the growth-factor-treated animals had a greater reduction in apomorphine-induced circling, this rate of reduction was not significantly greater when compared to controls. culture. Because these growth factors appear to work indirectly by stimulating astrocyte proliferation and neurotrophic factor production (18, 53, 61) , the ben- eficial effect of growth factor treatment may also carry over for a few days after transplantation.
In addition to antiapoptotic properties of some growth factors, treatment with inhibitors of specific proapoptotic pathways has proven to be neuroprotective (8) . Specifically, 2-h preincubation of rat ventral mesencephalic cell suspension with a caspase inhibitor, Ac-YVAD-cmk, tripled survival of transplanted dopamine neurons (47) . By contrast, transplantation of mouse ventral mesencephalon overexpressing the antiapoptotic protein Bcl-2 did not affect dopamine neuron survival, although fiber outgrowth was improved in such grafts (48) . Other neuroprotective treatments attempt to reduce free radical damage to transplanted cells. An approach that has shown promise in protecting transplanted dopamine neurons has treated cell suspensions with antioxidants such as lazaroids (37, 41) . The lazaroid trilazad mesylate improves survival of cultured human embryonic dopamine neurons (41) . Another effective strategy is transplantation of mesencephalic tissue overexpressing Cu/Zn Superoxide dismutase (38) .
Storing dopamine neurons prior to transplantation is critically important for accumulation of enough specimens for a transplant operation and to test tissue for infection. To store dopamine neurons prior to transplantation, freshly dissected ventral mesencephalon can be placed in hibernation medium at 10°C for up to several days (46, 54) . In our study, human embryonic brain tissue was stored at 10°C for up to several hours prior to dissection and was then placed in tissue culture for 2 weeks. We have found that dopamine cells in culture medium containing 5% human placental serum and a combination of IGF-I and bFGF have nearly 100% increased survival in transplants compared to cells cultured without growth factors. Others have shown that supplementation of hibernating cells with a combination of 8% human placental cord serum, GDNF and brain-derived neurotrophic factor improved THimmunoreactive cell survival by 40% (54) . Rat ventral mesencephalic tissue hibernated for 6 days in GDNFcontaining medium enhanced 6-week survival of transplanted dopamine neurons by 30% (2). Cryopreservation would be desirable for long-term storage of cells. Unfortunately, cryopreservation methods lead to unacceptable losses of rat and human mesencephalic cells, regardless if the cells are cryopreserved as tissue fragments or cell suspension (46) . Transplantation of cryopreserved human embryonic dopamine neurons reduced survival of dopamine neurons to only 9% of fresh tissue control grafts (27) .
Since bFGF can expand the progenitor population for dopamine neurons in embryonic rat cultures (6), it is possible that the IGF-I/bFGF combination may lead to more surviving dopamine neurons by promoting progenitor cell division in human fetal tissue strands. The observed increase in dopamine neuron survival in animals receiving IGF-I/bFGF-treated fetal tissue correlates with the greater improvement in behavioral deficits seen in animals receiving growth-factor-treated fetal tissue compared to control tissue. Although treatment with the IGF-I/bFGF combination led to faster 189 recovery of methamphetamine-induced circling, complete behavioral recovery was not achieved due to the slow maturation of human dopamine grafts in the rat host (4, 50) .
For the past 10 years, we have prepared embryonic tissue as strands for transplantation into patients with Parkinson's disease (20, 21) . Since we have shown that treatment of these strands with the combination of IGF-I and bFGF can nearly double the survival of dopamine neurons in transplants as well as significantly improve behavioral effects of transplants, growth factor pretreatment may prove useful for improving dopamine neuron survival after transplantation in Parkinson's disease patients.
